2018 Annual Meeting | P6 - Poster Session VI

Date Friday 04/27/18

Time 11:30 AM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology

CME Available 0.00 credit

Event Timeline
11:30 AM - 05:30 PM	Abstract	001 - Relationship Between Risk Factor Control and Physician Specialty in the Crest-2 Trial Tanya N. Turan, MD, FAAN
11:30 AM - 05:30 PM	Abstract	002 - Cavernous malformation - A rare complication of gamma knife surgery for Arterio-venous malformations Nagaraj Sanchitha Honganur
11:30 AM - 05:30 PM	Abstract	003 - Factors Influencing Stroke Awareness among Patients with Hypertension in a Tertiary Hospital of Nepal: A Cross-sectional Study Sulochana Ghimire, RN
11:30 AM - 05:30 PM	Abstract	004 - Barriers to Meeting Time Goals in Suspect Stroke Patients Receiving IV Thrombolysis Haitham Hussein, MD, FAAN
11:30 AM - 05:30 PM	Abstract	005 - Performance of a New "Code Stroke" Process in Hospitalized Patients in a Comprehensive Stroke Center in Minnesota
11:30 AM - 05:30 PM	Abstract	006 - Symptoms of a stroke: A diagnostic challenge. Eliz H. Agopian, MD
11:30 AM - 05:30 PM	Abstract	007 - Mimics of Spinal Dural Arteriovenous Fistula and Spinal Arteriovenous Malformation Patrick M. Chen, MD
11:30 AM - 05:30 PM	Abstract	008 - A randomized Controlled trail of Granulocyte colony stimulating factor(GCSF) intervention in acute Ischemic stroke (AIS) Sankar P. Gorthi, MD, FAAN
11:30 AM - 05:30 PM	Abstract	009 - Reversible Cerebral Vasoconstriction Syndrome Presenting as Third Cranial Nerve Palsy
11:30 AM - 05:30 PM	Abstract	010 - A Multidisciplinary Team Approach Improves Door to Groin Puncture Time for Endovascular Stroke Therapy in a Comprehensive Stroke Center Paul Wright, MD, FAAN
11:30 AM - 05:30 PM	Abstract	011 - Hypoglossal Cranial Nerve Palsy: Unusual Microvascular Complication Priyanka Chilakamarri, MD
11:30 AM - 05:30 PM	Abstract	012 - Wernicke Encephalopathy Masquerading As A Right Middle Cerebral Artery Territory Infarction Chi-Ying (Roy) Lin, MD, FAAN
11:30 AM - 05:30 PM	Abstract	013 - Neuroinvasiveness of West Nile Virus: A Case Report Ketan Jhunjhunwala, MD
11:30 AM - 05:30 PM	Abstract	014 - Sarcoid with Subacute Confusion Cassandra P. Cross, MD
11:30 AM - 05:30 PM	Abstract	015 - Cerebral missile injury with delayed diagnosis and minimal sequelae. Saurabh Singhal, MD, MBBS
11:30 AM - 05:30 PM	Abstract	016 - Convulsive Status Epilepticus Due to Dalfampridine in a Patient with Relapsing-Remitting Multiple Sclerosis Zeeshan Ali, MD
11:30 AM - 05:30 PM	Abstract	017 - A Unique Variant of a Partial Brown-Séquard Syndrome as the Result of Thoracic Fibrocartilaginous Embolism Timothy R. Fullam, MD, FAAN
11:30 AM - 05:30 PM	Abstract	018 - Thyrotoxic Periodic Paralysis in a Patient of Somali Descent: Case Report & Review of Literature. Marion Oliver, MD
11:30 AM - 05:30 PM	Abstract	019 - Creutzfeldt-Jakob Disease Presenting as Hashimoto's Encephalopathy: A Challenge to the Diagnostician Judea Wiggins, MD
11:30 AM - 05:30 PM	Abstract	020 - Severe Gabapentin Toxicity After Acute Kidney Injury in Hospitalized Patient with Acute Pain
11:30 AM - 05:30 PM	Abstract	021 - Conservative management of Aseptic Meningitis from Rupture of Brainstem Epidermoid Cyst Yuan Kit Christopher Chua, MBBS
11:30 AM - 05:30 PM	Abstract	022 - Transient Isolated Downbeating Vertical Nystagmus as a Complication of Intrathecal Anesthesia Kenneth Leung, MD
11:30 AM - 05:30 PM	Abstract	023 - Clinical characterization of Pramipexole induced edema and skin reaction in Parkinson Disease (PD) after one year of follow up Natalia Rincon, MD
11:30 AM - 05:30 PM	Abstract	024 - Abducens palsy following lumbar laminectomy; a rare presentation and review of intracranial hypotension Mark-Victor Siwoski, MD
11:30 AM - 05:30 PM	Abstract	025 - Trigeminal Neuralgia Exacerbated By Menstrual Cycle Anita K. Mehta, MD
11:30 AM - 05:30 PM	Abstract	026 - NA
11:30 AM - 05:30 PM	Abstract	027 - Levodopa-Carbidopa Intestinal Gel (LCIG) in Deep Brain Stimulation (DBS) Parkinson's Patients. Ahmad El Kouzi, MD, FAAN
11:30 AM - 05:30 PM	Abstract	028 - ODM-104 and Optimized Carbidopa Dose Show Beneficial Effect on Levodopa PK in Healthy Subjects Johanna Tuunainen
11:30 AM - 05:30 PM	Abstract	029 - Effects of Aerobic Exercise on the Cerebral White Matter in Parkinson's Disease Determined by Diffusion Tensor Imaging Ergun Y. Uc, MD
11:30 AM - 05:30 PM	Abstract	030 - A Dystonia-Related Microstructural Topography Identified in Diffusion MRI Koji Fujita, MD, PhD
11:30 AM - 05:30 PM	Abstract	031 - GABA Levels are Reduced in the Thalamus of Patients with Cervical Dystonia Christopher L. Groth, MD
11:30 AM - 05:30 PM	Abstract	032 - Altered Serum Lysosomal Hydrolase Activities in Parkinson's Disease Yoshiki Niimi
11:30 AM - 05:30 PM	Abstract	033 - Uniparental disomy causing Myoclonus Dystonia Syndrome associated with Russell Silver Syndrome: a case report Danielle S. Shpiner, MD
11:30 AM - 05:30 PM	Abstract	034 - Climbing fiber synaptic pathology in essential tremor: parallel evidence from both human and mouse models Sheng-Han Kuo, MD, FAAN
11:30 AM - 05:30 PM	Abstract	035 - A Family with Spinocerebellar Ataxia and Retinitis Pigmentosa Attributed to a Novel ELOVL4 Mutation Changrui Xiao, MD
11:30 AM - 05:30 PM	Abstract	036 - Serial CSF Studies of Anti-GAD Antibodies and GAD-IgG Intrathecal Synthesis in Stiff-Person Syndrome (SPS): Correlation with Disease Severity and Progression Haralambos Alexopoulos
11:30 AM - 05:30 PM	Abstract	037 - Hereditary Spastic Paraplegia: Clinical & Genetic Characterization of the Alberta Cohort Hammad Shaikh
11:30 AM - 05:30 PM	Abstract	038 - Astasia, Reach and Grasp Deficits Following a Bilateral Medio-dorsal Pulvinar Lesion Mathias Baehr
11:30 AM - 05:30 PM	Abstract	039 - CAPN1: novel mutations expanding the phenotype of hereditary spastic paraparesis. Aakash S. Shetty, MD
11:30 AM - 05:30 PM	Abstract	040 - Two novel mutations in CP associated with Aceruloplasminemia and basal ganglia cavitation Giulietta Riboldi, MD
11:30 AM - 05:30 PM	Abstract	041 - Psychosocial Profiles of Functional Movement Disorder (FMD) Patients compared to General Neurology Patients Alexandra E. Jacob, MS
11:30 AM - 05:30 PM	Abstract	042 - Immunotherapy-responsive chorea in a patient with antiphospholipid antibody syndrome and refractory Crohn's disease: A case report Neepa J. Patel, MD, FAAN
11:30 AM - 05:30 PM	Abstract	044 - ATP13A2-Related Heriditary Spastic Paraplegia (HSP) Marium Jamil, MBBS
11:30 AM - 05:30 PM	Abstract	045 - Phenomenology of Leg Stereotypy Syndrome Nicki Niemann, MD
11:30 AM - 05:30 PM	Abstract	046 - Refractory Myoclonus in Lance Adams Syndrome Responding to Brivaracetam Rahul Chandak, MBBS
11:30 AM - 05:30 PM	Abstract	047 - Breakdown of Affective-Cognitive Network in Functional Dystonia Elisa Canu
11:30 AM - 05:30 PM	Abstract	048 - Are There Two Different Forms of Functional Dystonia? A Multimodal Brain Structural Imaging Study Elisabetta Sarasso
11:30 AM - 05:30 PM	Abstract	049 - Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders Aikaterini Kompoliti, MD, FAAN
11:30 AM - 05:30 PM	Abstract	050 - Clinical Characteristics of Functional Movement Disorders: A Clinic-Based Study
11:30 AM - 05:30 PM	Abstract	051 - Family with brain calcification and SLC20A2 variant - possible anticipation Takuya Konno, MD, PhD
11:30 AM - 05:30 PM	Abstract	052 - Spasticity-related Involuntary Movements: A Cross-sectional Study Hesham A. Abboud, MD
11:30 AM - 05:30 PM	Abstract	053 - Pseudoathetosis Including Lingual Pseudoathetosis: Successful Treatment with Pregabalin Nabil M. Biary, MD, FAAN
11:30 AM - 05:30 PM	Abstract	054 - A quantitative study of "empty baskets" in essential tremor and cerebellar degenerative diseases Elan D. Louis, MD, MS, FAAN
11:30 AM - 05:30 PM	Abstract	055 - An Innovative, Non-Intrusive System for the Diagnosis of Tremor. Lin Zhang, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	056 - Thalamic Deep Brain Stimulation For Holmes Tremor Erik Z. Krause, DO
11:30 AM - 05:30 PM	Abstract	057 - Non-amnestic Cognitive Impairment in Essential Tremor (ET): Defining the Phenotype Nikita Urval, MD
11:30 AM - 05:30 PM	Abstract	058 - Neurologic Adverse Event Profile of MRI-Guided Focused Ultrasound Thalamotomy for Essential Tremor Paul S. Fishman, MD, PhD
11:30 AM - 05:30 PM	Abstract	059 - Repetitive Transcranial Magnetic Stimulation Therapy is a Potential Therapeutic Option for Primary Orthostatic Tremor. Wei Hu, MD, PhD
11:30 AM - 05:30 PM	Abstract	060 - A Phase 2 Efficacy Study of an Oral, Potent and Selective T-Type Calcium (Cav3) Modulator in Essential Tremor Patients (T-CALM): Design and Dose Selection Rationale Spyridon Papapetropoulos, MD, PhD
11:30 AM - 05:30 PM	Abstract	061 - Whole Exome Sequencing in Essential Tremor Isabel Alfradique-Dunham, MD
11:30 AM - 05:30 PM	Abstract	062 - Tremor Research Group Essential Tremor Rating Scale (TETRAS): Assessing Impact of Different Item Instructions Crystal J. Yeo, MD, PhD
11:30 AM - 05:30 PM	Abstract	063 - Orthostatic Tremor: Disease Impact and Progression Nirosen Vijiaratnam, MD
11:30 AM - 05:30 PM	Abstract	064 - Improved Atypical Tremor Control After Deep Brain Stimulation Targeting The Dentato-Rubro-Thalamic Tract Shivika Chandra, MD, FAAN
11:30 AM - 05:30 PM	Abstract	065 - An Unusual Presentation of Late-Onset Alexander Disease with Slow Orthostatic Tremor and a Novel GFAP Variant Derek W. Stitt, MD
11:30 AM - 05:30 PM	Abstract	066 - Quantitative tremor analysis of Holmes tremor: a case series Anh-Thu N. Vu, MD, MS
11:30 AM - 05:30 PM	Abstract	067 - Progression of Essential Tremor Over Time Using Digital Spirography in Patients on Stable Medication Doses Compared to Untreated Patients Katherine Longardner, MD
11:30 AM - 05:30 PM	Abstract	068 - The Effects of Amantadine on the Progression of Progressive Supranuclear Palsy (PSP) Amie L. Hiller, MD
11:30 AM - 05:30 PM	Abstract	069 - Multiple System Atrophy Presenting as Motor Neuron Disease Lauren Jackson, MD
11:30 AM - 05:30 PM	Abstract	070 - Background pathology of 'corticobasal degeneration (CBD) mimics' -Japanese validation study of CBD (J-VAC study) Takayoshi Shimohata, MD, FAAN
11:30 AM - 05:30 PM	Abstract	071 - Brain MRI findings in Woodhouse-Sakati Syndrome Ali H. Abusrair, MD
11:30 AM - 05:30 PM	Abstract	072 - Vocal cord "paralysis": The First Sign in Multiple System Atrophy Philip W. Tipton, MD
11:30 AM - 05:30 PM	Abstract	073 - Efficacy and Safety of BIIB092 in Patients with Progressive Supranuclear Palsy: PASSPORT Phase 2 Study Design
11:30 AM - 05:30 PM	Abstract	074 - Correlation of the UMSARS-II Motor Score to Commonly Affected Components of MSA-QoL in MSA Patients Matthew Remz, MD
11:30 AM - 05:30 PM	Abstract	075 - Ethnicity-specific clinical and neuroimaging characteristics in multiple system atrophy Hanim Kwon, MD
11:30 AM - 05:30 PM	Abstract	076 - THE ROLE OF NEURO-OPHTHALMOLOGY IN ATYPICAL PARKINSONISM: CLINICAL FINDINGS ON A STANDARDIZED OCULAR MOTOR EXAM Meagan D. Seay, DO
11:30 AM - 05:30 PM	Abstract	077 - A Prospective Clinical Cohort and Biorepository of Multiple System Atrophy (MSA).
11:30 AM - 05:30 PM	Abstract	078 - The Role of Neuro-Ophthalmology in Atypical Parkinsonism: Referral Patterns of Movement Disorders Specialists and Neuro-Ophthalmic Contribution to Diagnosis Andrea P. Lee, MD
11:30 AM - 05:30 PM	Abstract	079 - Parkinson Disease from long term drug abuse: Meta-analysis of amphetamine/methamphetamine and Parkinson Disease Richa Tripathi, MD
11:30 AM - 05:30 PM	Abstract	080 - Motor function impairment in chronic HIV is similar but less severe to that seen in Parkinson's disease Helen Bronte-Stewart, MD, MSE
11:30 AM - 05:30 PM	Abstract	081 - The 'Hot Cross Bun' Sign is Not Always Multiple System Atrophy: Etiologies of 10 Cases Christopher Y. Way, DO
11:30 AM - 05:30 PM	Abstract	082 - The Phonemic Verbal Fluency in Progressive Supranuclear Palsy (PSP) and Parkinson's Disease (PD): Relation with Executive and Language Function Measure. Sanjida Chowdhury, MBBS, MSc, MRCP
11:30 AM - 05:30 PM	Abstract	083 - Primary central nervous system lymphoma presenting as Parkinsonism with atypical MRI findings and elevated 14-3-3 protein Elanagan Nagarajan, MD
11:30 AM - 05:30 PM	Abstract	084 - NA
11:30 AM - 05:30 PM	Abstract	085 - Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations Mered Parnes, MD
11:30 AM - 05:30 PM	Abstract	086 - Wearable Inertial Sensor Technology Produces Endpoints with Good Reliability in Healthy Volunteers and Can Detect Changes in Parkinson Disease Patients with Levodopa Vesper F. Ramos, MD
11:30 AM - 05:30 PM	Abstract	087 - Changes in Cerebellar Nuclei and Granule Layer in a Mouse Model of Stereotypies Shannon L. Dean, MD
11:30 AM - 05:30 PM	Abstract	088 - Levodopa Induced Dyskinesias in Neurodegeneration with Brain Iron Accumulation due to a Heterozygous Mutation in C19orf12. Daniel Savitt, MD
11:30 AM - 05:30 PM	Abstract	089 - Phenotype and Cognitive Profile in ELOVL4-Associated SCA34 Marie Beaudin, MD
11:30 AM - 05:30 PM	Abstract	090 - Associations of genetic variants in COMT, BDNF, SNCA, MAPT genes with cognitive impairment in Parkinson's disease. Konstantin Senkevich, MD
11:30 AM - 05:30 PM	Abstract	091 - Glioblastoma Arising Within Sites of Encephalomalacia From Vascular brain injury: Two Novel Cases and a Review of the Literature Emily A. Ferenczi, MD, PhD
11:30 AM - 05:30 PM	Abstract	092 - Anti-Ma2 Encephalitis: Beyond Testicular Cancer - The Association with other Urogynecologic Tumors Mario Altikes Hazzan, MD
11:30 AM - 05:30 PM	Abstract	093 - Herpes simplex encephalitis after surgery for solid central nervous system tumors: A case report and systematic review of the literature Niloofar Yari, MD
11:30 AM - 05:30 PM	Abstract	094 - Spinal Leptomeningeal Dissemination as a Fatal Complication of Malignant Prolactinoma Justine E. Cormier, MD
11:30 AM - 05:30 PM	Abstract	095 - Intravascular Lymphoma Involving the CNS: a case report underscoring the importance of brain biopsy for progressive cerebrovascular disease Cheran Elangovan, MD
11:30 AM - 05:30 PM	Abstract	096 - Glioblastoma that Arises from Tumefactive Multiple Sclerosis
11:30 AM - 05:30 PM	Abstract	097 - An Unusual Case of Histiocytosis of the Central Nervous System involving the Leptomeninges Bhumika Balgobin, MD
11:30 AM - 05:30 PM	Abstract	098 - Neuropathy as an adverse effect of vascular endothelial growth factor tyrosine kinase inhibitors, a meta-analysis of randomized clinical trials Bhaskar Roy, MD, FAAN
11:30 AM - 05:30 PM	Abstract	099 - CASPR2 Autoimmunity Preceding the Diagnosis of Thyroid Cancer Akanksha Sharma, MD
11:30 AM - 05:30 PM	Abstract	100 - Atypical Papillary Glioneuronal Tumor: A Neoplasm in Search of a Grade J. Clay Goodman, MD, FAAN
11:30 AM - 05:30 PM	Abstract	101 - Rare Malignant Transformation of an Epidermoid Cyst Alexander C. Ou, MD
11:30 AM - 05:30 PM	Abstract	102 - Lymphomatosis Cerebri: An interesting case report and review of literature Dhiren R. Patel, MBBS
11:30 AM - 05:30 PM	Abstract	103 - Intra-axial CNS Involvement of Langerhans Cell Histiocytosis Scott G. Turner, MD
11:30 AM - 05:30 PM	Abstract	104 - Concurrent Leptomeningeal and Parenchymal Brain Metastases in Primary Invasive Ductal Cell Carcinoma of the Breast Armin Maghsoudlou, MD
11:30 AM - 05:30 PM	Abstract	105 - Primary Leptomeningeal Medulloblastoma: A Rare Presentation Ankita Ghosh, MD
11:30 AM - 05:30 PM	Abstract	106 - A Case of Intravascular Large B Cell Lymphoma Shilpa Chaku, MD
11:30 AM - 05:30 PM	Abstract	107 - Leptomeningeal disease in a case of recurrent uveal melanoma Sujan Teegala S. Reddy, MD
11:30 AM - 05:30 PM	Abstract	108 - DELAYED CEREBRAL PSEUDOANEURYSM FORMATION FROM DISSEMINATION OF ATRIAL MYXOMA Ashley M. Roque, MD
11:30 AM - 05:30 PM	Abstract	109 - Primary Central Nervous System Lymphoma Mimicking Tumefactive Multiple Sclerosis
11:30 AM - 05:30 PM	Abstract	110 - Rapidly Progressive Demyelinating Lesions in a patient with Intravascular B Cell Lymphoma: A Diagnostic Dilemma Natasha Hameed, MD
11:30 AM - 05:30 PM	Abstract	111 - Cerebellar ataxia following allogenic stem cell transplant: A clinical approach to a differential diagnosis Catherine Maurice, MD
11:30 AM - 05:30 PM	Abstract	112 - CMV Colitis: A rare complication in a LGI-1 antibody encephalitis patient treated with Cellcept Muhammad Amjad Hameed, MD
11:30 AM - 05:30 PM	Abstract	113 - Intravascular Lymphoma; a rare mimic of Acute Disseminating Encephalomyelitis Mina Lobbous, MD
11:30 AM - 05:30 PM	Abstract	114 - Metastatic Melanoma presenting as an Intraventricular non-bleeding Mass Sana Somani, MD, MBBS
11:30 AM - 05:30 PM	Abstract	115 - A Rare Presentation of Multiple Myeloma Leptomeningeal Carcinomatosis Lalanthica Yogendran, MD
11:30 AM - 05:30 PM	Abstract	116 - Multi Cranial Neuropathy Secondary To Primary Glioblastoma Of Trigeminal Nerve: Case Report Mohamad Orabi, MD
11:30 AM - 05:30 PM	Abstract	117 - Desmoplastic Medulloblastoma: A literature review and case report investigating most common clinical presentations in the adult Jonathan Greco, DO
11:30 AM - 05:30 PM	Abstract	118 - Case Presentation Of CRPM5 Encephalitis Secondary To A Thymoma. Jessy Walia, MBBS
11:30 AM - 05:30 PM	Abstract	119 - Cranial Nerve Palsies as a Manifestation of Prostate Metastatic Disease: An Uncommon Diagnosis Sonia M. Caraballo-Cartagena, MD
11:30 AM - 05:30 PM	Abstract	120 - Angioimmunoblastic T-Cell Lymphoma with Central Nervous System Involvement Mimicking Acute Stroke Nasima D. Shadbehr, DO
11:30 AM - 05:30 PM	Abstract	121 - Unsual Case of Ring Enhancing Multifocal Radiation Induced Necrosis Nurose Karim, MD
11:30 AM - 05:30 PM	Abstract	122 - Spinal dural arteriovenous fistula and concomitant intramedullary spinal lesion. Fabio Nascimento, MD
11:30 AM - 05:30 PM	Abstract	123 - Melanoma and AMPA Encephalitis- First Reported Case Ali Daneshmand, MD
11:30 AM - 05:30 PM	Abstract	124 - Capturing Capecitabine Neurotoxicity: Delayed Clinical Manifestations of Capecitabine-Related Multifocal Leukoencephalopathy John C. Greenert, MD
11:30 AM - 05:30 PM	Abstract	125 - Primary CNS Posttransplant Lymphoproliferative Disease (PCNS-PTLD): Recognizing the Entity and Minimizing Toxicity in Renal Transplant Patients Na Tosha N. Gatson, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	126 - Immune Mediated Neuritis and Polyradiculopathy due to Checkpoint Inhibitors Rahul Chandak, MBBS
11:30 AM - 05:30 PM	Abstract	127 - The Gray Area of Dueling Immunity: Clinical Challenges in Treating Concurrent Multiple Sclerosis and Primary Brain Tumor Muhammad Taimur A. Malik, MD
11:30 AM - 05:30 PM	Abstract	128 - Meningioma resection surgery in elderly patients: An analysis of a national database Mina Lobbous, MD
11:30 AM - 05:30 PM	Abstract	129 - Patterns of Care in Recurrent Glioblastoma in the Era of Molecular Diagnosis Ibrahim Migdady, MD
11:30 AM - 05:30 PM	Abstract	130 - Eleven Month Progression Free Survival on Vemurafenib Monotherapy in a Patient with Recurrent and Metastatic BRAF V600E Mutated Glioblastoma WHO Grade IV Kanita Beba Abadal, MD
11:30 AM - 05:30 PM	Abstract	131 - Treatment at Academic Centers is Associated with Improved Survival in Patients with Low-grade Glioma Jay-Jiguang Zhu, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	132 - Botulinum Toxin as Prophylaxis for Adverse Dermatologic Effects of Tumor-Treatment Fields (TTF) Julia N. Bucklan, DO
11:30 AM - 05:30 PM	Abstract	133 - Steroid-responsive Dementia with Immunotherapy for Metastatic Melanoma Javier Gonzalez, MD
11:30 AM - 05:30 PM	Abstract	134 - Acute stroke treated with tissue plasminogen activator in a patient with GBM Archana Hinduja, MD
11:30 AM - 05:30 PM	Abstract	135 - A case of rare Papillary Tumor of the Pineal Region (PTPR) with leptomeningeal metastases treated with Bevacizumab and Chemotherapy Austin T. Momii, MD
11:30 AM - 05:30 PM	Abstract	136 - Two Cases of Pembrolizumab Therapy for CNS lymphoma Jerome J. Graber, MD, MPH, FAAN
11:30 AM - 05:30 PM	Abstract	137 - Hodgkin's lymphoma presenting as paraneoplastic rhombencephalitis: do plasmapheresis and IVIG play a therapeutic role? Tigran Kesayan, MD
11:30 AM - 05:30 PM	Abstract	138 - Validation of a novel scoring system to predict rapid meningioma growth David O. Kamson, MD
11:30 AM - 05:30 PM	Abstract	139 - Elevated YKL-40 level in Cerebrospinal Fluid is Associated with Glioblastoma Recurrence Jay-Jiguang Zhu, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	140 - Neurocognitive Function and Quality of Life in Stable Grade 2 and 3 Glioma Patients
11:30 AM - 05:30 PM	Abstract	141 - Prediction of Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) gene amplification for newly diagnosed glioblastoma patients with radiomic analysis on Apparent Diffusion Coefficient (ADC) maps Stefania Maraka, MD
11:30 AM - 05:30 PM	Abstract	142 - LZTR1 mutations associated with greater pain among patients with schwannomatosis Justin T. Jordan, MD, MPH, FAAN
11:30 AM - 05:30 PM	Abstract	143 - Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 - 2013. Solomon Ambe, MBBS
11:30 AM - 05:30 PM	Abstract	144 - Refractory status epilepticus as a predictor of tumor progression and poor prognostic indicator Dana L. Vanino, DO
11:30 AM - 05:30 PM	Abstract	145 - NF1 Associated Extra-Optic Gliomas: The Importance of Age, Imaging, and Clinical Presentation Over Histology Alone Marina K. Girgis
11:30 AM - 05:30 PM	Abstract	146 - Assessing cerebral metabolic activity of an Atkins-based diet using MR Spectroscopy - A feasibility study in glioma patients Karisa C. Schreck, MD, PhD
11:30 AM - 05:30 PM	Abstract	147 - Development and Validation of Immunoassays for Paraneoplastic Neurological Disorders using a Parallel Nanoscale Microfluidic Analysis System
11:30 AM - 05:30 PM	Abstract	148 - Molecular Classification of Glioblastoma in the Clinical Setting Bernadette Kalman, MD, PhD, Dsc, FAAN, FAAN
11:30 AM - 05:30 PM	Abstract	149 - Ultra-High Gradient Diffusion MRI Reveals Distinct Microstructural Changes in Gliomas Before and After Radiation Therapy Ina Ly, MD
11:30 AM - 05:30 PM	Abstract	150 - Long-Term Outcomes of Adult Patients with Ependymoma Zachary Vaslow, MD
11:30 AM - 05:30 PM	Abstract	151 - Clinical evaluation of fitness to drive in patients with brain metastases Cristina Valencia Sanchez, MD
11:30 AM - 05:30 PM	Abstract	152 - Gliomatosis Cerebri: Predispositions and Predictors of Behavior Fernando Santos Pinheiro, MD
11:30 AM - 05:30 PM	Abstract	153 - Prospective Assessment of End of Life Symptoms and Quality of Life in Glioblastoma Tobias Walbert, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	154 - A Neurologists Foray into Gamma Knife: Lessons Learned from the first 50 cases: Glen H. Stevens, DO, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	155 - The Development of Ventriculomegaly in Glioblastoma (GBM) Patients Caroline Miranda, MD
11:30 AM - 05:30 PM	Abstract	157 - Effect of Health Disparities on Overall Survival of Patients with Glioblastoma Jacob Mandel, MD
11:30 AM - 05:30 PM	Abstract	158 - Adult Pilocytic Astrocytoma: Clinical Management and Prognostic Factors Ovais Inamullah, MD
11:30 AM - 05:30 PM	Abstract	159 - Leptomeningeal dissemination from low-grade neuroepithelial CNS tumors in adults: a 15-year experience
11:30 AM - 05:30 PM	Abstract	160 - Predictors of Early and Recurrent Seizure in Low-Grade Glioma Jasmin T. Jo, MD
11:30 AM - 05:30 PM	Abstract	161 - Clinical manifestations and location of brain metastases as prognostic markers. Bernardo Cacho Diaz, MD, FAAN
11:30 AM - 05:30 PM	Abstract	162 - Semi-Automated MRI Segmentation Workflow for Glioblastoma Treated by Tumor Treating Fields
11:30 AM - 05:30 PM	Abstract	163 - Association of Reduced DNA Repair Gene Expression on Chromosome Arms 1p and 19q with Increased Chemosensitivity in 1p19q Codeleted Lower-grade Gliomas Natalie Neale, MD
11:30 AM - 05:30 PM	Abstract	164 - Systemic staging in patients with lymphomatous brain lesions Rachna Malani, MD
11:30 AM - 05:30 PM	Abstract	165 - CSF Lactate Dehydrogenase as a prognostic marker in neoplastic meningitis Bernardo Cacho Diaz, MD, FAAN
11:30 AM - 05:30 PM	Abstract	166 - Incidence of Primary Brain and Central Nervous System Tumors Among Hispanic Population in Texas 1995-2013 Solomon Ambe, MBBS
11:30 AM - 05:30 PM	Abstract	167 - Leukopenia as a Possible Biomarker for Overall Survival in Glioblastoma Patients Treated with Temozolomide Ka-wai G. Ho, MD
11:30 AM - 05:30 PM	Abstract	168 - A case series of thalamic gliomas harboring H3 K27M mutation Divya B. Mella, MD
11:30 AM - 05:30 PM	Abstract	169 - Retrospective Review of Surgical Tissue Sample Processing for Molecular Diagnosis of Gliomas at DHMC Hena Waseem, MD
11:30 AM - 05:30 PM	Abstract	170 - Undetected CSF and Low Serum Epstein Barr Virus PCRs in EBV-Positive CNS Post Transplant Lymphoproliferative Disorder Shreya Nayak, MD
11:30 AM - 05:30 PM	Abstract	171 - The ENIGMA Cancer and Chemotherapy Working Group and Cancer-Related Cognitive Impairment Mark Shiroishi
11:30 AM - 05:30 PM	Abstract	172 - NA
11:30 AM - 05:30 PM	Abstract	173 - Memantine ER With an AChEI Improves Individual SIB Scores Compared With AChEI Alone: Post Hoc Analyses From a Randomized, Double-blind, Placebo-controlled Study George Grossberg, MD
11:30 AM - 05:30 PM	Abstract	174 - Characterization of the Selective In Vivo and In Vitro Binding Properties of Crenezumab: Insights into Crenezumab's Unique Mechanism of Action
11:30 AM - 05:30 PM	Abstract	175 - Memantine Added to Background Cholinesterase-Inhibitors Reduces Agitation in Alzheimer's Disease Alireza Atri, MD, PhD
11:30 AM - 05:30 PM	Abstract	176 - Memantine ER and Donepezil Treatment Maintains Cognitive Improvements Versus Donepezil Monotherapy: Post Hoc Analyses From a Placebo-controlled Study in Patients with Moderate-to-Severe Alzheimer's Disease Alireza Atri, MD, PhD
11:30 AM - 05:30 PM	Abstract	177 - Memantine With Cholinesterase Inhibitors Maintains Improvements of Psychiatric Symptoms vs Cholinesterase Inhibitors Alone: Post Hoc Analyses From 3 Randomized, Double-blind, Placebo-controlled Studies in Patients With Alzheimer's Disease Jeffrey L. Cummings, MD, FAAN
11:30 AM - 05:30 PM	Abstract	178 - Memantine and Cholinesterase Inhibitor Use in Alzheimer Disease Trials: Potential for Confounding by Indication Branko N. Huisa, MD
11:30 AM - 05:30 PM	Abstract	179 - Optimizing the Gantenerumab Phase 3 Dosing Regimen Through PK/PD Modeling and Clinical Trial Simulations
11:30 AM - 05:30 PM	Abstract	180 - The effect of social relationships and leisure activities in prevention of Motoric Cognitive Risk Syndrome.
11:30 AM - 05:30 PM	Abstract	181 - Establishing digital biomarkers for clinical trials. Neil W. Thomas, MD
11:30 AM - 05:30 PM	Abstract	182 - Safety, Tolerability and Pharmacokinetics of Crenezumab in Mild-to-Moderate AD Patients Treated with Escalating Doses for up to 32.3 Months Helen C. Lin, MD
11:30 AM - 05:30 PM	Abstract	183 - The construction of evidence-based profile for Alzheimer's prevention: a meta-analysis and systematic review assessing the current evidence based on prospective observational studies and randomized controlled trials Wei Xu
11:30 AM - 05:30 PM	Abstract	184 - NSAID Use and the Prevention of Alzheimer's Disease: A Meta-Analysis Xi Li, MD
11:30 AM - 05:30 PM	Abstract	185 - Does Sleep Quality Moderate the Effect of Vitamin D Intake on Risk for Dementia? Chen Zhao, MD
11:30 AM - 05:30 PM	Abstract	186 - Brief cognitive screening detects baseline cognitive impairment and predicts in-hospital complexity David P. Bissig, MD
11:30 AM - 05:30 PM	Abstract	187 - Characterization of Fall-Related Injuries in Progressive Supranuclear Palsy Susanna S. Kwok
11:30 AM - 05:30 PM	Abstract	188 - Potential Resource Utilization Benefits of Delaying the Progression of Mild Cognitive Impairment Wan Tsong
11:30 AM - 05:30 PM	Abstract	189 - Changes in Depression Severity Correlate with Quality of Life in Alzheimer Disease: a Longitudinal Study Elizabeth Joe, MD
11:30 AM - 05:30 PM	Abstract	190 - Sleep and Subjective Cognitive Complaints in cognitively healthy older adults: Results from two cohorts Angeliki Tsapanou, PhD
11:30 AM - 05:30 PM	Abstract	191 - Quality of Sleep Among Caregivers of Alzheimer Disease Patients
11:30 AM - 05:30 PM	Abstract	192 - Correlates of Behavioral and Psychological Symptoms of Dementia and impact on caregiver distress - A study from Eastern India Adreesh Mukherjee, MD
11:30 AM - 05:30 PM	Abstract	194 - Factors Associated with Clinician Adherence to Clinical Practice Guidelines for the Diagnosis of Alzheimer's Dementia Ahmed A. Malik, MD
11:30 AM - 05:30 PM	Abstract	195 - Using digital biomarkers as objective measures of activity and effort related to caregiving. Neil W. Thomas, MD
11:30 AM - 05:30 PM	Abstract	196 - Can Dementia Caregivers Define Dementia? Joel I. Shenker, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	197 - The Prevalence of the Frontal Lobe Syndrome in a population-based sample of 65 year olds: Preliminary Results from the Great-Age Study
11:30 AM - 05:30 PM	Abstract	198 - Rapidly Progressive Dementia: Towards a Better Diagnostic Approach Mariano Marrodan, MD
11:30 AM - 05:30 PM	Abstract	199 - Impaired Clock Drawing Test in Progressive Supranuclear Palsy and Corticobasal Syndrome: Differences from Alzheimer Disease David Geldmacher, MD
11:30 AM - 05:30 PM	Abstract	200 - Influence of Digital Proficiency, Age, ��ɫ��, and Cognitive Impairment/Diagnosis on Time to Complete Digital Cognitive Testing using the electronic Self-Administered Gerocognitive Examination (eSAGE) Douglas W. Scharre, MD, FAAN
11:30 AM - 05:30 PM	Abstract	201 - Intracerebral Hemorrhage after IV tPA for Stroke as Early Symptoms of ANCA-Associated Vasculitis Neda Zarghami Esfahani, MD
11:30 AM - 05:30 PM	Abstract	202 - Thrombotic Therapy for Acute Stroke in Pratient with Refractory Epilepsy and an Implanted Responsive Neurostimulation Device with Intravenous Recombinant Tissue Plasminogen Activator Heidi L. Henninger, MD, FAAN
11:30 AM - 05:30 PM	Abstract	203 - Uncomplicated intravenous thrombolysis after lumbar puncture: A case report Shashank Shekhar, MBBS
11:30 AM - 05:30 PM	Abstract	204 - Mechanical Thrombectomy With Concomittant In-situ RTPA infusion And Systemic Anticoagulation In A Case Of Refractory Intracranial Hypertension Secondary To Extensive Cerebral Venous Thromboses. Vijayaleskhmi Nair, MD
11:30 AM - 05:30 PM	Abstract	205 - IV tPA Administration in Chronic Aortic Dissection Soha Sadeghikhah, MD
11:30 AM - 05:30 PM	Abstract	206 - Bloodstream infection is associated with infectious intracranial aneurysm in left ventricular assist device Tiffany H. Pike-Lee, MD
11:30 AM - 05:30 PM	Abstract	207 - Infectious Intracranial Aneurysm During Cardiac Valve Repair Cory J. Rice, MD
11:30 AM - 05:30 PM	Abstract	208 - Brain aneurysm associated with atrial myxoma.
11:30 AM - 05:30 PM	Abstract	209 - Arteriovenous Fistula Presenting as Progressive Bifrontal Intracerebral Hemorrhage Benjamin C. Cox, MD
11:30 AM - 05:30 PM	Abstract	210 - Distinct Presentation of Dural AV Fistula as Primary Intraventricular Hemorrhage Isolated in Cerebral Aqueduct Priyadarshee Patel, MD
11:30 AM - 05:30 PM	Abstract	211 - CAMS Type II with Unusual Involvement of Temporal Lobe Tushar Bajaj
11:30 AM - 05:30 PM	Abstract	212 - A Case of Monocular Vision Loss in the Setting of Internal Carotid Artery Stenosis and Carotid-Cavernous Fistula. Kishan Patel, MD
11:30 AM - 05:30 PM	Abstract	213 - Radiographic Efficacy of Middle Meningeal Artery Embolization in Treatment of Chronic Subdural Hematoma Nathan S. Farkas, MD
11:30 AM - 05:30 PM	Abstract	214 - Subclavian Steal Syndrome secondary to Dialysis AVF treated with Balloon Mounted Stent Shashank Agarwal, MD, MBBS
11:30 AM - 05:30 PM	Abstract	215 - Cavernous Sinus Thrombophlebitis with secondary Vasculitis and Ischemic Stroke Shahrzad Deliran, MD
11:30 AM - 05:30 PM	Abstract	216 - A Case of Bilateral Globi Pallidi Infarcts with Methamphetamine Use
11:30 AM - 05:30 PM	Abstract	217 - Lateral Medullary Syndrome due to Left Vertebral Artery Occlusion in a Boy Post Flexion Neck Injury Abdulla Alawadhi, MBBS
11:30 AM - 05:30 PM	Abstract	218 - Traumatic Carotid Artery Dissection in Teenagers After Football Injuries Yvo A. Rodriguez-Linares, MD
11:30 AM - 05:30 PM	Abstract	219 - Recurrent Vertebral Arteries Dissection Yuri Bronstein, MD
11:30 AM - 05:30 PM	Abstract	220 - High Resolution Vessel Wall MRI in Diagnosis of MCA Dissection: A Case Report and Review of the Literature Marion Oliver, MD
11:30 AM - 05:30 PM	Abstract	221 - Giant Carotid Pseudoaneurysm Amenable to Pipeline Stenting in a Patient with Ehlers-Danlos Type IV Blake E. Senay, DO
11:30 AM - 05:30 PM	Abstract	222 - Embolic Stroke Due To Thrombosed Left Subclavian Vein
11:30 AM - 05:30 PM	Abstract	223 - Carotid Steal Syndrome Mimicking Subclavian Steal Phenomenon due to Innominate Artery Stenosis Kavneet Kaur, MD
11:30 AM - 05:30 PM	Abstract	224 - May?Thurner Syndrome as a Cause of Embolic Stroke of Undetermined Source in a Young Patient: A Case Report Andres De Leon, MD
11:30 AM - 05:30 PM	Abstract	225 - Homocysteinuria due to cystathionine ?-synthase deficiency manifesting as Moyamoya disease and Henoch-Schonlein Purpura Rodica Di Lorenzo, MD
11:30 AM - 05:30 PM	Abstract	226 - Stroke Prevention in a Young Lady with Antiphospholipid Syndrome and Libman-Sacks Endocarditis Amelia K. Adcock, MD
11:30 AM - 05:30 PM	Abstract	227 - Rheumatoid Meningitis: An Unusual Stroke Mimic Joshua Trujeque
11:30 AM - 05:30 PM	Abstract	228 - A Case of Primary CNS Angiitis Presenting as Longitudinally Extensive Transverse Myelitis Frank S. Benesh, MD
11:30 AM - 05:30 PM	Abstract	229 - Irreversible and Severe Vision Loss Despite Aortic and Carotid Revascularization in Takayasu’s Arteritis Michael Christiansen, MD
11:30 AM - 05:30 PM	Abstract	230 - Neurobrucellosis:Unusual Cause of Stroke in a Young Patient Walaa Mohammed, Jr., MD
11:30 AM - 05:30 PM	Abstract	231 - Would you use new oral anticoagulants (NOACs) for thromboprophylaxis in patients with an underlying hypercoagulable state? A literature review through a case report. Bhavika Kakadia, DO
11:30 AM - 05:30 PM	Abstract	232 - Left Ventricular Non-Compaction: A Rare Cause of Stroke in the Young Mohammad Ridha, MD
11:30 AM - 05:30 PM	Abstract	233 - Atrio-esophageal fistula presenting with acute devastating strokes Kauroon M. Darya, DO
11:30 AM - 05:30 PM	Abstract	234 - Subdural hematoma secondary to spontaneous rupture of pseudoaneurysm of middle meningeal artery Guru Ramaiah, MD
11:30 AM - 05:30 PM	Abstract	235 - Intraparenchymal Intracerebral Hemorrhage Complicating Venomous Snakebite in Nigeria: A Case Report
11:30 AM - 05:30 PM	Abstract	236 - Is Patent Foramen Ovale in-rest a risk factor for Embolic strokes of undetermined source?
11:30 AM - 05:30 PM	Abstract	237 - Diagnostic yield of TEE in patients with Cryptogenic stroke and TIA with normal TTE: A systematic review and meta-analysis. Shamik Shah, MBBS
11:30 AM - 05:30 PM	Abstract	238 - Diagnostic Yield of Transesophageal Echocardiogram in Stroke in the Young Muhammad Ahmed, MD
11:30 AM - 05:30 PM	Abstract	239 - Transthoracic Echocardiogram v/s Transesophageal Echocardiogram in Identification of Intracardiac Thrombus in Acute Ischemic Stroke Patients Sajid Suriya, MD
11:30 AM - 05:30 PM	Abstract	240 - Diagnosis Value of Prehospital Electrocardiogram (ECG) vs Post Hospitalization 30-day Event Monitoring in Detecting Cardiac Arrhythmia in Ischemic Stroke Patients
11:30 AM - 05:30 PM	Abstract	241 - Is Lactate Dehydrogenase level a Biomarker of Ischemic Stroke in Ventricular Assist Device? Catherine Hassett, MD
11:30 AM - 05:30 PM	Abstract	242 - The Etiology of Left Ventricular Assist Device Associated Ischemic Stroke Catherine Hassett, MD
11:30 AM - 05:30 PM	Abstract	243 - Cryptogenic Ischemic Stroke Patients with Left Atrial Enlargement are More Likely to Have Paroxysmal Atrial Fibrillation Tracy Ander, DO
11:30 AM - 05:30 PM	Abstract	244 - Comparison of Implantable Loop Recorder and Event Monitors for Diagnosis of Atrial fibrillation in Patients with Cryptogenic Stroke Smeer Salam, MD, MBBS
11:30 AM - 05:30 PM	Abstract	245 - Risk of ischemic stroke recurrence in patients with atrial fibrillation diagnosed after stroke Luciano A. Sposato, MD
11:30 AM - 05:30 PM	Abstract	246 - Heart - brain relationship: cerebrovascular disease and its cardiac impact Guido D. Vazquez II, PhD
11:30 AM - 05:30 PM	Abstract	248 - Atherosclerotic Risk Factor Prevalence in Young Adults with Stroke and Acute Myocardial Infarction Michelle H. Leppert, MD
11:30 AM - 05:30 PM	Abstract	249 - Pre-existing Cardiac Thrombus in Patient of Acute Ischemic Stroke with Large Vessel Occlusion Sajid Suriya, MD
11:30 AM - 05:30 PM	Abstract	250 - Door In Door Out over Telestroke, two comprehensive stroke centers experience Sami Alkasab, MD
11:30 AM - 05:30 PM	Abstract	251 - Evaluation of the Tele-Stroke Mimic Score (TM-Score) for Prehospital Distinction Between Stroke and Stroke Mimic Patients Syed F. Ali, MD
11:30 AM - 05:30 PM	Abstract	253 - Impact of the Implementation of an Extended Stroke Code Window on Stroke Code Volume and Yield Lili Velickovic Ostojic, MD
11:30 AM - 05:30 PM	Abstract	254 - Importance of Awareness in Wake-Up Stroke Shuichi Suzuki, MD, PhD
11:30 AM - 05:30 PM	Abstract	255 - NA
11:30 AM - 05:30 PM	Abstract	256 - NA
11:30 AM - 05:30 PM	Abstract	257 - NA
11:30 AM - 05:30 PM	Abstract	258 - NA
11:30 AM - 05:30 PM	Abstract	260 - Artisanal "Hemp Extract" Experience in Utah Epilepsy Cohort: Survey Results Carey A. Wilson, MD
11:30 AM - 05:30 PM	Abstract	261 - The Effects of Assessing Obstructive Sleep Apnea Using a Prompt in the Electronic Health Record in Adult Patients with Epilepsy. Siddharth Gupta, MD
11:30 AM - 05:30 PM	Abstract	262 - Muscle Tone in the Rapid Eye Movement Sleep of Persons with Epilepsy Marcus Ng, MD
11:30 AM - 05:30 PM	Abstract	263 - Heart Rate Variability in Epilepsy: A Potential SUDEP Risk Biomarker Ken Myers, MD, PhD
11:30 AM - 05:30 PM	Abstract	264 - Antiepileptic Drugs and Suicidality in Veterans with Epilepsy Shawniqua Williams Roberson, MD
11:30 AM - 05:30 PM	Abstract	265 - Can volumes of cortical and subcortical structures predict pre and post-laser ablation psychiatric symptoms in patients with temporal lobe epilepsy? CARLOS MAURICIO M. MILLAN, MD
11:30 AM - 05:30 PM	Abstract	266 - Assessment of Cognitive Functioning In Patients with Epilepsy- Preliminary Findings Allison Hoynes
11:30 AM - 05:30 PM	Abstract	267 - A Systematic Review of Seizures and Epilepsy in Leukodystrophies Royce Sumayo
11:30 AM - 05:30 PM	Abstract	268 - Clinical Correlates of Negative Health Events in a Research Sample with Epilepsy Neha Kumar
11:30 AM - 05:30 PM	Abstract	269 - Association Between Socioeconomic Variables and Seizure Frequency Jaime Olivas
11:30 AM - 05:30 PM	Abstract	270 - Psychosocial and Physiologic Characteristics of Patients with Non-epileptic Events: A Retrospective Study of Rural Patients Dipali P. Nemade, MD
11:30 AM - 05:30 PM	Abstract	271 - Knowledge,perceptions and attitudes towards schoolchildren with epilepsy among school teachers in two cities in south western Nigeria Morenikeji Komolafe, MD
11:30 AM - 05:30 PM	Abstract	272 - The Direct Cost Burden of Illness (BOI) of Lennox-Gastaut Syndrome (LGS) in the US Georgia D. Montouris, MD
11:30 AM - 05:30 PM	Abstract	274 - Healthcare expenditure patterns among elderly with seizure in the United States: Medical Expenditure Panel Survey, 2003-2014. Alain Z. Lekoubou Looti, MD
11:30 AM - 05:30 PM	Abstract	275 - Preliminary Report of Psychogenic Non-Epileptic Seizure Diagnosis Among Veterans From 2004-2014 Arjumond Khan
11:30 AM - 05:30 PM	Abstract	276 - The Burden of Seizures in Adults with Tuberous Sclerosis Complex (TSC) and Epilepsy: Data from a Specialized Center in Netherlands
11:30 AM - 05:30 PM	Abstract	277 - Use of Antiepileptic Drugs among Patients with Tuberous Sclerosis Complex Related Epilepsy who Initiated an Oral mTOR Inhibitor Steven P. Sparagana, MD, FAAN
11:30 AM - 05:30 PM	Abstract	278 - Quality Measures in the Epilepsy Monitoring Unit Kristen Malloy
11:30 AM - 05:30 PM	Abstract	279 - Impact of Medicaid antiepileptic drug formulary restrictions on health outcomes and costs Jesse Fishman, PharmD
11:30 AM - 05:30 PM	Abstract	280 - Drivers of Epilepsy-related Cost of Care in an Integrated Healthcare System
11:30 AM - 05:30 PM	Abstract	281 - The association between office-based provider visits and emergency department utilization among publicly insured epilepsy patients.
11:30 AM - 05:30 PM	Abstract	282 - Use of Templates in Implementing AAN Epilepsy Quality Measurement Set in Neurology Resident Clinic David Q. Mao, MD
11:30 AM - 05:30 PM	Abstract	283 - Predictors of Clinically Meaningful Improvements in Health-Related Quality of Life Among Adults With Partial-Onset Epilepsy: A Pooled Analysis From Two Eslicarbazepine Acetate Monotherapy Trials Joyce A. Cramer
11:30 AM - 05:30 PM	Abstract	284 - Persistent Symptoms of Depression and Anxiety Disorders in Veterans with Epilepsy: Can it be Prevented? Mark Armanious, MD
11:30 AM - 05:30 PM	Abstract	285 - Suicidal Ideation among Epilepsy Patients at a Sub-Saharan Health Facility in Calabar, Nigeria Sidney Oparah, MD
11:30 AM - 05:30 PM	Abstract	286 - Improving Antiepileptic Medication Administration Time to Status Epilepticus Patients Jennifer Haynes, MD
11:30 AM - 05:30 PM	Abstract	287 - Reduced Healthcare Costs Among Clobazam-Treated Patients With Lennox?Gastaut Syndrome John M. Stern, MD, FAAN
11:30 AM - 05:30 PM	Abstract	288 - Cognitive Burden of Seizures in Patients with Tuberous Sclerosis Complex (TSC) for Health-Related Quality of Life (HRQoL) and Functional Status
11:30 AM - 05:30 PM	Abstract	289 - Improving Epilepsy Care in Older Adults in the Long-Term Care Setting: Effect of Online Medical ��ɫ�� on Risks and Recognition Among Neurologists
11:30 AM - 05:30 PM	Abstract	290 - The Direct Cost Burden of Illness (BOI) of Dravet Syndrome (DS) in the US Anup D. Patel, MD, FAAN
11:30 AM - 05:30 PM	Abstract	291 - Incremental expenditures of stroke among adults with epilepsy in the United States: Medical Expenditure Panel Survey, 2003-2014. Alain Z. Lekoubou Looti, MD
11:30 AM - 05:30 PM	Abstract	292 - Epilepsy in Elderly: Prevalence and Etiologic in Urban Population of Consolación Del Sur Municipality, A Door-To-Door Survey
11:30 AM - 05:30 PM	Abstract	293 - Adherence with Extended-Release Oxcarbazepine (Oxtellar XR®) vs. Immediate-Release Oxcarbazepine: Analysis of Pooled Data from Four National Pharmacy Claims Databases Shannon W. Mendes, PhD
11:30 AM - 05:30 PM	Abstract	294 - NA
11:30 AM - 05:30 PM	Abstract	295 - Using Botox, biofeedback and lifestyle modifications as therapy for medication refractory post-traumatic headache (PTHA) in the military population of Okinawa. Nawaz Hack, MD
11:30 AM - 05:30 PM	Abstract	296 - Concussion and the Risk of Suicide: A Systematic Review and Meta-Analysis Matthew J. Burke, MD, FRCPC
11:30 AM - 05:30 PM	Abstract	297 - Premorbid ADHD and Concussion in Pediatric Population Megan B. Edwards, DO
11:30 AM - 05:30 PM	Abstract	298 - Value of Occupational Therapy in a Pediatric Concussion Clinic Madison B. Harris, OT
11:30 AM - 05:30 PM	Abstract	299 - Amygdala Disconnection in Pediatric Traumatic Brain Injury (TBI) Kevin Bickart, MD, PhD
11:30 AM - 05:30 PM	Abstract	300 - High Sensitivity C-Reactive Protein: Potential Biomarker of Inflammation in Acute mTBI Teena Shetty, MD, FAAN
11:30 AM - 05:30 PM	Abstract	301 - Concussion Knowledge in Nurses: Educating the front line Philip Rosenbaum
11:30 AM - 05:30 PM	Abstract	302 - Distinct 6-Month Functional Outcome Trajectories and Predictors after Traumatic Brain Injury Raquel Gardner, MD
11:30 AM - 05:30 PM	Abstract	303 - Recovery Time, Risk Factors, and Volumetric Analysis in Acute mTBI Teena Shetty, MD, FAAN
11:30 AM - 05:30 PM	Abstract	304 - Chronic mTBI: Who is at Risk, A Retrospective Analysis of mTBI Patients Presenting to the TBI Clinic at a Large Military Base Aaron A. Daley, MD
11:30 AM - 05:30 PM	Abstract	305 - Use of Event Related Potential Markers in Patients with Traumatic Brain Injury Tad D. Seifert, MD
11:30 AM - 05:30 PM	Abstract	306 - Retinoid X Receptor Alpha Polymorphisms may Associate with Markers of Inflammation, Edema, and Outcome after TBI Benjamin Zusman, MD
11:30 AM - 05:30 PM	Abstract	307 - Never Say Never: Imaging in Concussion Joshua L. Kamins, MD
11:30 AM - 05:30 PM	Abstract	308 - Exertional Effects of Neurocognitive Testing in Post-Acute Concussion Patients Aliyah R. Snyder, PhD
11:30 AM - 05:30 PM	Abstract	309 - Guided Physical Exertion in Sports-Related Concussion Patients Michael Popovich, MD
11:30 AM - 05:30 PM	Abstract	310 - The incidence of the Cavum Septum Pellucidum (CSP) in a population exposed to Head Trauma Ryan Hubbard, MD
11:30 AM - 05:30 PM	Abstract	311 - Association of Neurocognitive and Neuropsychiatric Alterations with the Findings in Diffusion Tensor Imaging in pediatric patients with concussion: Pilot study. larry rubin
11:30 AM - 05:30 PM	Abstract	312 - Tonsillar Contusion Associated With Benign Tonsillar Ectopia Following Minor Head Trauma Yonatan Serlin, MD
11:30 AM - 05:30 PM	Abstract	313 - Early Changes in Expression of Inflammatory Pathways may play a role in Cerebral Hypoxia Following TBI Benjamin Zusman, MD
11:30 AM - 05:30 PM	Abstract	314 - Case Series of Cervical Strain Mimicking Concussion in High School Athletes Lisa M. Stropp, MD
11:30 AM - 05:30 PM	Abstract	315 - Clinical Evaluation of Concussion: Review of Current Guidelines and Practices Mary Kelley, DO
11:30 AM - 05:30 PM	Abstract	316 - Measuring Postural Stability in Adolescent Population at Baseline: the Balance Error Scoring System vs Sensory Evaluation Test Zhe Wang
11:30 AM - 05:30 PM	Abstract	317 - Difference in pre-season King-Devick (K-D) scores in Recreational vs Competitive youth soccer players. Bert B. Vargas, MD, FAAN
11:30 AM - 05:30 PM	Abstract	318 - Treating Prolonged Post-Concussion Symptoms in a Pediatric Patient with the Simultaneous Application of Cognitive Behavioral Therapy and Subthreshold Exercise: A Case Study
11:30 AM - 05:30 PM	Abstract	319 - Assessing Clinical Recommendations: Focus on Post-Traumatic Headaches
11:30 AM - 05:30 PM	Abstract	320 - Surfer's Myelopathy in Pediatric population Vijeta Shukla, MD
11:30 AM - 05:30 PM	Abstract	321 - Using an Eye Tracker as an Assessment Tool for Concussion Diagnosis Atefeh Katrahmani
11:30 AM - 05:30 PM	Abstract	322 - Characterization of Deep, Supratentorial Intracerebral Hemorrhage in the Ethnic/Racial Variations of ICH Study Audrey Leasure
11:30 AM - 05:30 PM	Abstract	323 - Fentanyl Associated Infection Rates in Patients with Spontaneous Intracerebral Hemorrhage Admitted to the Neuro Intensive Care Unit Aaron Desai, MD, MBBS
11:30 AM - 05:30 PM	Abstract	324 - How does pre-existing hypertension affect patients with intracerebral hemorrhage? David Valentine, MD
11:30 AM - 05:30 PM	Abstract	325 - Change in Practice Pattern in Management of Aneurysmal Subarachnoid Hemorrhage During Hospitalization over a 5-year Period - A Single Center Perspective Swathy Chandrashekhar, MD
11:30 AM - 05:30 PM	Abstract	326 - Risk Factors for Mortality after Spontaneous Subarachnoid Hemorrhage and External Validation of a Prediction Model
11:30 AM - 05:30 PM	Abstract	327 - Initial Neutrophil-Lymphocyte Ratio Predicts Intracerebral Hemorrhage Outcomes at Discharge Rashi K. Krishnan, MD
11:30 AM - 05:30 PM	Abstract	328 - Healthcare-Associated Infections after Spontaneous Subarachnoid Hemorrhage Najayeb Alabdulraheem, MD
11:30 AM - 05:30 PM	Abstract	329 - IS NIMODIPINE UNDERUTILIZED IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE? Arnavaz Hajizadeh Barfejani
11:30 AM - 05:30 PM	Abstract	330 - Paroxysmal sympathetic hyperactivity with dystonia following bilateral thalamic and cerebellar hemorrhage: a case report
11:30 AM - 05:30 PM	Abstract	331 - A Rare Case of Metastatic Synovial Sarcoma Presenting as a Fatal Hemorrhagic Stroke Kyle Carpenter, DO
11:30 AM - 05:30 PM	Abstract	332 - Predictors of Worsening Perihematomal Edema in Intracerebral Hemorrhage (ICH) Mini Singh, MBBS
11:30 AM - 05:30 PM	Abstract	333 - Validating the Use of Prophylactic Antiepileptic Drugs in Patients with Subcortical Intracranial Hemorrhage in a Large Urban Hospital. Rajanigandhi Hanumanthu, MD
11:30 AM - 05:30 PM	Abstract	334 - Bedside Ultrasonography of the Inferior Vena Cava for Volume Status Assessment Following Aneurysmal Subarachnoid Hemorrhage Mohammad Hajighasemi-Ossareh, MD
11:30 AM - 05:30 PM	Abstract	335 - Communication Priorities in Spontaneous Intracerebral Hemorrhage (CPsICH): A Survey-based Study Incorporating Patient and Physician Perspectives Jonathan Krett, MD
11:30 AM - 05:30 PM	Abstract	336 - NA
11:30 AM - 05:30 PM	Abstract	337 - NA
11:30 AM - 05:30 PM	Abstract	338 - NA
11:30 AM - 05:30 PM	Abstract	339 - SCA2 Presenting as Focal Dystonia Nan Cheng, MD
11:30 AM - 05:30 PM	Abstract	340 - Neuropathic Tremor Secondary to Chronic Immune Demyelinating Polyneuropathy with Robust Response to Intravenous Immune Globulin Christopher C. Spears, MD
11:30 AM - 05:30 PM	Abstract	341 - In the eye of the beholder: a patient with catatonia found to have progressive encephalomyelitis with rigidity and myoclonus. Natalie P. Witek, MD
11:30 AM - 05:30 PM	Abstract	342 - Dysphagia in Patients with Friedreich's Ataxia Amir Besharat, DO
11:30 AM - 05:30 PM	Abstract	343 - Cerebrospinal fluid flow dynamics in Huntington's disease using phase contrast MRI: a pilot cross-sectional study
11:30 AM - 05:30 PM	Abstract	344 - Bilateral Facial Spasm following Guillian-Barre Syndrome Zain Guduru, MD, FAAN
11:30 AM - 05:30 PM	Abstract	345 - Effects of Opicinumab on Patient-Reported Outcomes in Participants with Relapsing Multiple Sclerosis: A Post-Hoc Analysis of the Phase 2 SYNERGY Study Jennifer Petrillo Billet, PhD
11:30 AM - 05:30 PM	Abstract	346 - Comparison of 12 month changes in Brain Volume among Long Term Users of Natalizumab versus Healthy Controls in Multiple Sclerosis: Year one Analysis of a Two-Year Longitudinal Observational Study Enrique Alvarez, MD, PhD
11:30 AM - 05:30 PM	Abstract	347 - Dimethyl Fumarate in Relapsing Remitting Multiple Sclerosis: 24 Months Observations of the Effects of Dose Reduction on Lymphopenia Ka-Ho Wong
11:30 AM - 05:30 PM	Abstract	348 - Baseline cognitive function of patients with relapsing remitting multiple sclerosis is associated with therapeutic response to Natalizumab Daniel Golan, MD
11:30 AM - 05:30 PM	Abstract	349 - A Real-Life Study of Alemtuzumab: Impact of Previous Therapies and Washout Period on Disease Activity Francesco Sacca, MD, FAAN
11:30 AM - 05:30 PM	Abstract	350 - Autologous Haematopoietic Stem Cell Transplantation in Treatment Naïve Patients with Rapidly Evolving Severe Multiple Sclerosis Joyutpal Das, MBBS
11:30 AM - 05:30 PM	Abstract	351 - Extended interval dosing of natalizumab in MS; a New Zealand experience Calvin Chan, MbChB
11:30 AM - 05:30 PM	Abstract	352 - Alemtuzumab treatment in Multiple Sclerosis: real clinical experience in the Northwest of Spain Ana Lopez Real
11:30 AM - 05:30 PM	Abstract	353 - Safety and Efficacy of Ocrelizumab in Multiple Sclerosis Patients with increased disability Channa Kolb, MD
11:30 AM - 05:30 PM	Abstract	354 - Effect of Fingolimod 0.5 mg/day vs Placebo on Two Newly Developed Expanded Disability Status Scale (EDSS) Subscales for Patients with Relapsing-Remitting MS: EDSS Factor Analysis Gary R. Cutter, PhD
11:30 AM - 05:30 PM	Abstract	355 - Long-term follow up of treatment with interferon beta 1-b: a 23-year observational study in a single center cohort of 87 patients with multiple sclerosis Helena Bulka, DO
11:30 AM - 05:30 PM	Abstract	356 - Real-World Experience with Ocrelizumab Brandon P. Moss, MD
11:30 AM - 05:30 PM	Abstract	357 - Efficacy and Safety of Alemtuzumab in Real World Italian Patients Switching from Natalizumab Antonio Bertolotto, MD, FAAN
11:30 AM - 05:30 PM	Abstract	358 - Supporting personalized treatment decisions in relapsing remitting multiple sclerosis (RRMS) Stefan Braune
11:30 AM - 05:30 PM	Abstract	359 - Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis Ariel L. Miller, MD, PhD
11:30 AM - 05:30 PM	Abstract	360 - EVOLVE-MS-1: A Phase 3, Open-Label, Long-Term Safety Study of ALKS 8700 in Relapsing-Remitting Multiple Sclerosis Robert T. Naismith, MD, FAAN
11:30 AM - 05:30 PM	Abstract	361 - Analysis of 6-month Confirmed Disability Progression in RRMS Patients Treated with Subcutaneous Interferon beta-1a Schiffon Wong
11:30 AM - 05:30 PM	Abstract	362 - Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS I Extension Aaron L. Boster, MD
11:30 AM - 05:30 PM	Abstract	363 - Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS II Extension Barry A. Singer, MD
11:30 AM - 05:30 PM	Abstract	364 - Disability Improvement Is Observed in Each Functional System in Alemtuzumab-Treated Patients With Active RRMS: Results From CARE-MS II Extension Samuel F. Hunter, MD, PhD
11:30 AM - 05:30 PM	Abstract	365 - MD1003 in Progressive Multiple Sclerosis: 24-Month Brain Volume Changes of the MS-SPI Trial Douglas L. Arnold, MD, FAAN
11:30 AM - 05:30 PM	Abstract	366 - Durable Efficacy and Safety With Alemtuzumab in CARE-MS I Patients Switching From SC IFNB-1a: 5-Year Follow-up (TOPAZ Study) Brian Steingo, MD
11:30 AM - 05:30 PM	Abstract	367 - Active RRMS Patients Treated with Alemtuzumab Experience Durable Reductions in MRI Disease Activity and Slowing of Brain Volume Loss: 7-Year Follow-up of CARE-MS II Patients (TOPAZ Study) Daniel Pelletier, MD
11:30 AM - 05:30 PM	Abstract	368 - Alemtuzumab Provides Durable Efficacy and Safety Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS II (TOPAZ Study) Bart Van Wijmeersch, MD, PhD
11:30 AM - 05:30 PM	Abstract	369 - Durable Clinical Outcomes With Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS II Patients (TOPAZ Study) Barry A. Singer, MD
11:30 AM - 05:30 PM	Abstract	370 - Baseline Characteristics of the CHORDS Study Population: A Phase III Trial to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With RRMS Who Had Disease Activity With Prior Disease-Modifying Therapies Anthony Reder, MD
11:30 AM - 05:30 PM	Abstract	371 - Effectiveness and safety of fingolimod in Spanish Relapsing-Remitting Multiple Sclerosis patients in clinical practice (Fingoview study): Subanalysis of patients previously treated with first line injectable disease-modifying treatment
11:30 AM - 05:30 PM	Abstract	372 - Evaluation of the Long-term Treatment Effect of Teriflunomide on Cognitive Outcomes and Association With Brain Volume Change: Data From TEMSO and its Extension Study Till Sprenger
11:30 AM - 05:30 PM	Abstract	373 - Real-world Effectiveness of Delayed-release Dimethyl Fumarate in Relapsing-remitting Multiple Sclerosis Patients Who Are Treatment-naïve or Treated With Only One Prior Therapy: Final Results from the EFFECT Study Jonathan C. Calkwood, MD
11:30 AM - 05:30 PM	Abstract	374 - Long-term Disability Outcomes in Teriflunomide-Treated Patients in TEMSO and TOWER: An Analysis Utilizing the Topographical Model of MS Stephen Krieger, MD, FAAN
11:30 AM - 05:30 PM	Abstract	375 - Durable Reduction in MRI Disease Activity and Slowing of Brain Volume Loss in Alemtuzumab-Treated Patients With Active RRMS: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study) Anthony Traboulsee, MD
11:30 AM - 05:30 PM	Abstract	376 - Durable Clinical Efficacy of Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study) Patrick Vermersch
11:30 AM - 05:30 PM	Abstract	377 - A Long-term Experience with Fingolimod: Evaluation of Safety, Disability, and Treatment Satisfaction in Patients with Relapsing-Remitting Multiple Sclerosis Nadia Tenenbaum, MD
11:30 AM - 05:30 PM	Abstract	378 - Long-term efficacy, safety, and tolerability of three-times weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 5-year results of the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study Jessica K. Alexander, PhD
11:30 AM - 05:30 PM	Abstract	379 - Longer duration of natalizumab exposure may lessen return of disease activity following a switch from natalizumab to an oral therapy: modelling real-world data from relapsing-remitting multiple sclerosis (RRMS) patients in the TYSABRI® Observational Program (TOP) Helmut Butzkueven, MD, MBBS
11:30 AM - 05:30 PM	Abstract	380 - Alemtuzumab Improves Patient-reported Quality of Life Outcomes in Patients With Relapsing-remitting Multiple Sclerosis: Results From the CARE-MS I Extension Study Rafael Arroyo
11:30 AM - 05:30 PM	Abstract	381 - Long-term effect of natalizumab in a French cohort of patients with relapsing-remitting multiple sclerosis: TYSTEN cohort Kevin Bigaut
11:30 AM - 05:30 PM	Abstract	382 - Delayed-release Dimethyl Fumarate Demonstrates Long-term, Sustained Efficacy in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis followed for at least Eight-Years Ralf Gold, MD
11:30 AM - 05:30 PM	Abstract	383 - Real-world improvement across functional systems (FS) in relapsing-remitting multiple sclerosis (RRMS) patients treated with natalizumab in the TYSABRI® Observational Program (TOP) Heinz Wiendl, MD, FAAN
11:30 AM - 05:30 PM	Abstract	385 - Long-Term Efficacy of Early Fingolimod Treatment in Young Adult Patients With Relapsing Multiple Sclerosis Tanuja Chitnis, MD, FAAN
11:30 AM - 05:30 PM	Abstract	386 - Peginterferon Beta-1a Demonstrated Sustained Efficacy in Newly Diagnosed Relapsing Multiple Sclerosis (RMS) Patients Treated up to 4 Years: Subgroup Analysis of ATTAIN Thomas F. Scott, MD
11:30 AM - 05:30 PM	Abstract	387 - Impact of the Presence of Gadolinium-Enhancing (Gd+) Lesions at Baseline on No Evidence of Disease Activity (NEDA) Status in Patients Treated with Subcutaneous Interferon beta-1a (scIFN?-1a): A Post-hoc Analysis of REFLEXION Mark S. Freedman, MD, FAAN
11:30 AM - 05:30 PM	Abstract	388 - Long-Term Disease Control with Fingolimod in RRMS Patients With Active Disease
11:30 AM - 05:30 PM	Abstract	389 - Long-term Disability Outcomes in Patients Treated With Teriflunomide for up to 14 Years: Group- and Patient-Level Data From the Phase 2 Extension Study Mark S. Freedman, MD, FAAN
11:30 AM - 05:30 PM	Abstract	391 - Long-term Efficacy and Safety Outcomes of Teriflunomide Treatment in TEMSO and TOWER Mariana Espinosa-Polanco
11:30 AM - 05:30 PM	Abstract	392 - Alemtuzumab Improves Patient-reported Quality of Life Outcomes in Patients With Rapidly Evolving Severe Relapsing-remitting MS: Results From the CARE-MS I Extension Study Rafael Arroyo Gonzalez
11:30 AM - 05:30 PM	Abstract	393 - PANGAEA: 5 years effectiveness of fingolimod in daily clinical practice Tjalf Ziemssen, MD, FAAN
11:30 AM - 05:30 PM	Abstract	394 - One- and two-year Annualized Relapse Rate and NEDA-3 in Italian patients treated with fingolimod: preliminary results from the GENIUS (FinGolimod Real World EvideNce Italian mUlticenter observational Study in Multiple Sclerosis) Study.
11:30 AM - 05:30 PM	Abstract	395 - Spanish Registry of patients with Multiple Sclerosis (MS) treated with fingolimod (GILENYA Registry): safety and effectiveness after four years. Patients without previous treatment subanalysis Jose Meca Lallana, MD
11:30 AM - 05:30 PM	Abstract	396 - Treatment Satisfaction With Teriflunomide in Patients Switching From a Prior Disease-Modifying Therapy: Results From the Phase 3 TENERE and Phase 4 Teri-PRO Clinical Trials Patrick Vermersch
11:30 AM - 05:30 PM	Abstract	397 - Neuromyelitis Optica Spectrum Disorders with Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies in Turkish Population: A Comparative Study Egemen Idiman, MD
11:30 AM - 05:30 PM	Abstract	398 - Neuromyelitis Optica Mimicking Lateral Medulla Stroke Lily Chau, MD
11:30 AM - 05:30 PM	Abstract	399 - MRI Trident sign trumps Aquaporin-4-IgG ELISA in discriminating Spinal Cord Sarcoidosis misdiagnosed as Neuromyelitis Optica Spectrum Disorder Evan A. Jolliffe, MD
11:30 AM - 05:30 PM	Abstract	400 - Axonal damage evolution in multiple sclerosis and neuromyelitis optica spectrum disorder: evaluation with optical coherence tomography Letizia M. Leocani, MD
11:30 AM - 05:30 PM	Abstract	401 - Neuromyelitis Optica spectrum disorder and menstruation Shervin Badihian, MD
11:30 AM - 05:30 PM	Abstract	402 - The Relationship Between Neuromyelitis Optica (NMO), Relapsing Remitting Multiple Sclerosis (RRMS) And Systemic Autoimmunity. Ashwaq Alshahrani, MD
11:30 AM - 05:30 PM	Abstract	403 - Unusual Presentation of Neuromyelitis Optica Spectrum Disorder (NMOSD) Pritikanta Paul, MD
11:30 AM - 05:30 PM	Abstract	404 - Obstetric Outcomes in Mexican Patients with NMO-IgG (+) Neuromyelitis Optica Guillermo R. Delgado-Garcia, MD, MSc
11:30 AM - 05:30 PM	Abstract	405 - Neuromyelitis Optica Spectrum Disorders Presenting with Area Postrema and Acute Brainstem Syndromes with Concomitant Myasthenia Gravis Jeffrey B. Schachter, MD
11:30 AM - 05:30 PM	Abstract	406 - Anti-CRMP5 Optic Neuropathy Associated with Oral Squamous-Cell Carcinoma Cigdem Isitan-Alkawadri, MD
11:30 AM - 05:30 PM	Abstract	407 - Presentation of Neuromyelitis Optica (NMO) in patients from different racial groups: analysis of the global NMOBase Registry Ilya Kister, MD, FAAN
11:30 AM - 05:30 PM	Abstract	408 - Contributors to Long-Term Disability in Patients with Neuromyelitis Optica Spectrum Disorder Michael Levy, MD, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	409 - The Mayo Clinic Glial Autoimmunity Study: Glial autoantibody (AQP4/MOG/GFAP) serostatus in recurrent longitudinally extensive transverse myelitis Jiraporn Jitprapaikulsan, MD
11:30 AM - 05:30 PM	Abstract	410 - Sensitivity and specificity for NMO IgG assays in Australia and New Zealand
11:30 AM - 05:30 PM	Abstract	411 - Brain and spinal cord MRI lesion criteria differentiate AQP4- and MOG-disease from MS Catalina Bensi
11:30 AM - 05:30 PM	Abstract	412 - Are Recurrent Myelitis a Prodromic Phase of Inflammatory Diseases or a Distinct Inflammatory Condition? Laura Cacciaguerra, MD, PhD
11:30 AM - 05:30 PM	Abstract	413 - The Analysis of Association Between the Disability and Multiple Autoantibodies in Neuromyelitis Optica Spectrum Disorder (NMOSD) Hyelim Lee, MD
11:30 AM - 05:30 PM	Abstract	414 - Long term Mortality in Neuromyelitis Optica Spectrum Disorder Iris V. Marin Collazo, MD
11:30 AM - 05:30 PM	Abstract	415 - Serum IL-27, IL-23 and IL-35 Levels in Neuromyelitis Optica Spectrum Disorders with Aquaporin-4 and Multiple Sclerosis Egemen Idiman, MD
11:30 AM - 05:30 PM	Abstract	416 - A Report of Seronegative Neuromyelitis Optica (NMO) in the Setting of Acute HIV Infection Mahsa Khayat-Khoei, MD
11:30 AM - 05:30 PM	Abstract	417 - Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses Nicholas L. Zalewski, MD
11:30 AM - 05:30 PM	Abstract	418 - Long term outcomes of patients treated for Idiopathic Relapsing Transverse Myelitis Viviana I. Orozco, MD
11:30 AM - 05:30 PM	Abstract	419 - Side effects of long-term RTX treatment in NMOSD patients: hypogammaglobulinemia and impairment of specific humoral immunity. Antonio Bertolotto, MD, FAAN
11:30 AM - 05:30 PM	Abstract	420 - Characterization and Alternative Diagnoses in Patients with False-positive Aquaporin-4 Autoantibody Detection by Enzyme-Linked Immunosorbent Assay (ELISA) Jon Williams, DO, PhD
11:30 AM - 05:30 PM	Abstract	421 - Acute Flaccid Myelitis - Epidemiology and Clinical Characteristics, United States, August 2014 - August 2017
11:30 AM - 05:30 PM	Abstract	422 - Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in a Patient with Ataxia, Diplopia, and an Enhancing Cerebellar Lesion Josef M. Gutman, MD
11:30 AM - 05:30 PM	Abstract	423 - Unique Presentation of acquired Longitudinally Extensive Transverse Myelitis and GBS Overlap Syndrome following Tdap Vaccination Dharampreet Singh, MD
11:30 AM - 05:30 PM	Abstract	424 - Neuromyelitis Optica Spectrum Disorder (NMOSD) in Active Duty Service Members Jon Williams, DO, PhD
11:30 AM - 05:30 PM	Abstract	425 - NA
11:30 AM - 05:30 PM	Abstract	426 - NA
11:30 AM - 05:30 PM	Abstract	427 - NA
11:30 AM - 05:30 PM	Abstract	428 - NA
11:30 AM - 05:30 PM	Abstract	429 - The Frequency of LRP4 Autoantibodies in Serum Specimens Sent to a Clinical Laboratory for Myasthenia Gravis Testing Sat Dev Batish, PhD, FAAN
11:30 AM - 05:30 PM	Abstract	430 - Pre-operative Management of Myasthenia Gravis in Patients Undergoing Surgery Tarun D. Singh, MBBS
11:30 AM - 05:30 PM	Abstract	431 - MuSK (Muscle Specific Kinase) Positive Myasthenia: Grave Prognosis Or Undue Prejudice? Priyanka Samal
11:30 AM - 05:30 PM	Abstract	432 - Estimation of EQ5D Health Utilities from a Myasthenia Gravis Specific Questionnaire Carolina Barnett Tapia, MD
11:30 AM - 05:30 PM	Abstract	433 - Readmission After Myasthenia Gravis Discharge in a Nationally Representative Sample Sujata P. Thawani, MD
11:30 AM - 05:30 PM	Abstract	434 - Myasthenia Gravis: Pregnancy and Neonatal Complications in Argentina. Lucia J. Zavala
11:30 AM - 05:30 PM	Abstract	435 - Myasthenia Symptom Burden, Sleep and Fatigue: Are they related? Ning S. Yang, MD
11:30 AM - 05:30 PM	Abstract	436 - Effect of Coexisting Autoimmune Disorders on Clinical Outcome in Myasthenia Gravis Patients: An Analysis from National Inpatient Database Malik Adil, MBBS
11:30 AM - 05:30 PM	Abstract	437 - Myasthenia Gravis after Vaccination in Adults the United States: A Report from the CDC/FDA Vaccine Adverse Event Reporting System (1990-2017) Nirav Sanghani, MBBS
11:30 AM - 05:30 PM	Abstract	438 - Unusual electrodiagnostic feature in patient with severe Myasthenia Gravis Karan Tarasaria, MBBS
11:30 AM - 05:30 PM	Abstract	439 - B-cell depletion in late-onset myasthenia gravis is safe and effective; a case series Supreet K. Sahai, MD
11:30 AM - 05:30 PM	Abstract	440 - Myasthenia Gravis - Ice-Pack Test Diagnostic Accuracy with Meta-Analysis Divya Arya, MD
11:30 AM - 05:30 PM	Abstract	441 - Evolution of clinical outcome in thymectomy for Myasthenia Gravis Jose Maria Cabrera Maqueda
11:30 AM - 05:30 PM	Abstract	442 - Elevation of Acetylcholine Receptor Antibodies in association with Prolonged Clinical Deterioration in Post-thymomectomy Myasthenia Gravis Rejo Cherian, MD
11:30 AM - 05:30 PM	Abstract	443 - Prednisone Side Effects are Common and Associated with Unwillingness to Accept a Dose Increase: Survey Result from MGFA Registry Ikjae Lee, MD
11:30 AM - 05:30 PM	Abstract	444 - Lambert-Eaton Myasthenia With and Without Cancer: Clinical Characteristics and Long-term Survival Shruti M. Raja, MD
11:30 AM - 05:30 PM	Abstract	445 - Treatment Refractory Ocular Symptoms in Myasthenia Gravis: Clinical and Therapeutic Profile Bhavana Sharma, MD
11:30 AM - 05:30 PM	Abstract	446 - Perioperative management of myasthenia gravis patients undergoing general anesthesia, a survey from multiple institutions. Sarah Madani, MD
11:30 AM - 05:30 PM	Abstract	447 - Disposition of Patients Diagnosed with Myasthenia Gravis Crisis, a New York State Planning and Research Cooperation System Database Analysis (1998-2014) Shuja Sheikh, MD
11:30 AM - 05:30 PM	Abstract	448 - Cognitive Biases at Bedside Resulting in Diagnostic Error of Myasthenia Gravis Natalie Kukulka, MD
11:30 AM - 05:30 PM	Abstract	449 - An Atypical Presentation of Congenital Myasthenic Syndrome Masquerading as Acquired Myasthenia Gravis Tijil Agarwal, MD
11:30 AM - 05:30 PM	Abstract	450 - Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy Dana S. Cooper, MD
11:30 AM - 05:30 PM	Abstract	451 - Description of a Myasthenia Gravis population from a referral South-American center. Valeria Alvarez
11:30 AM - 05:30 PM	Abstract	452 - 3,4 DAP (FIRDAPSE) Improves Progressive Dok-7 Congenital Myasthenic Syndrome (CMS) Weakness: Clinical Experience in Two Patients Shoichi Shimamoto, MD
11:30 AM - 05:30 PM	Abstract	453 - Fifty Years of Steroid Treatment of Myasthenia Gravis Charles A. Cape, MD, FAAN
11:30 AM - 05:30 PM	Abstract	454 - Congenital Myasthenic Syndrome with Tubular Aggregates and Agrin Mutations Francis M. Huttinger, MD
11:30 AM - 05:30 PM	Abstract	455 - Myasthenia Gravis Therapeutic Intervention Charges Comparison. A New York State Planning and Research Cooperation System Database Analysis (1998-2014) Janaki Patel, MD
11:30 AM - 05:30 PM	Abstract	456 - Tacrolimus Inhibits Th1 and Th17 Responses in MuSK-MG Patients Yingkai Li, MD, PhD
11:30 AM - 05:30 PM	Abstract	457 - Double Trouble: NXP2 mediated dermatomyositis presenting in a patient with myasthenia gravis Maria Gaughan, MBBS
11:30 AM - 05:30 PM	Abstract	458 - Comparing the Effectiveness of IVIG and PLEX for Treatment of Neuromuscular Disorders Ehtesham Khalid, MBBS
11:30 AM - 05:30 PM	Abstract	459 - Effects of early nonsteroidal oral immunomodulatory therapy in myasthenia gravis Christine Lu, MD
11:30 AM - 05:30 PM	Abstract	460 - Racial and Ethnic Differences in Hospital Utilization, Life Saving Procedures and Palliative Care Among Patients with Amyotrophic Lateral Sclerosis (ALS) Darine Kassar, MD
11:30 AM - 05:30 PM	Abstract	461 - Association between Amyotrophic Lateral Sclerosis and Diabetes Mellitus Type I and II, a New York State Planning and Research Cooperation System Database Analysis (1998-2014) Abu Nasar
11:30 AM - 05:30 PM	Abstract	462 - The role of pre-morbid diabetes on developing ALS: a population-based study Umberto Manera, MD
11:30 AM - 05:30 PM	Abstract	463 - The Palmomental reflex Predicts Earlier Corticobulbar Involvement in ALS
11:30 AM - 05:30 PM	Abstract	464 - Post-hoc analyses of an Edaravone Controlled Clinical Trial Suggest Similar Rates of Decline in King's Amyotrophic Lateral Sclerosis (ALS) Clinical Staging across Subgroups Charlotte A. Merrill, PhD
11:30 AM - 05:30 PM	Abstract	465 - Ibudilast - Phosphodiesterase Type 4 Inhibitor - Bi-Modal Therapy with Riluzole in Early [ Not Requiring Non-Invasive Ventilation ( NIV ) ] Cohort ( EC ) and Advanced [ Requiring NIV ] ( ANC ) Amyotrophic Lateral Sclerosis ( ALS ) Patients - Single-Center Adaptive Design Six-Month Double-Blind ( DB ) - Placebo-Controlled Phase 1b/2a Epoch Followed by Six-Month Open Label Extension ( OLE ) Epoch, Washout ( WO ) and Post-Washout Epoch ( PWO ) - Final Report and Future Directions Benjamin R. Brooks, MD, FAAN
11:30 AM - 05:30 PM	Abstract	466 - Clinical Course of Pathologically Confirmed Japanese Amyotrophic Lateral Sclerosis, a Retrospective Institute-based Study Kiyonobu Komai, MD
11:45 AM - 11:50 AM	Discussion	P6.027
11:50 AM - 11:55 AM	Discussion	P6.028
11:55 AM - 12:00 PM	Discussion	P6.029
12:00 PM - 12:05 PM	Discussion	P6.030
12:05 PM - 12:10 PM	Discussion	P6.031
12:10 PM - 12:15 PM	Discussion	P6.032
12:15 PM - 12:20 PM	Discussion	P6.033
12:20 PM - 12:25 PM	Discussion	P6.034
12:25 PM - 12:30 PM	Discussion	P6.035
12:30 PM - 12:35 PM	Discussion	P6.036
04:00 PM - 05:30 PM	Discussion	Poster Author Standby Time

Faculty Disclosures
Spyridon Papapetropoulos, MD, PhD	Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Janice M. Massey, MD, FAAN	Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Calvin Chan, MbChB	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
Mitchell G. Miglis, MD, FAAN	Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care.
Fatta B. Nahab, MD, FAAN	Dr. Nahab has received personal compensation for serving as an employee of Neuron23. Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ActualSignal. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Attune Neurosciences, Inc.. Dr. Nahab has stock in Biogen. Dr. Nahab has received personal compensation in the range of $500-$4,999 for serving as a DSMB Member with NIH.
Michelle M. Mielke, PhD	Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Joseph Y. Matsumoto, MD	Dr. Matsumoto has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Michael Chez, MD, FAAN	Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Tad D. Seifert, MD	Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen Pharmaceuticals. Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly Pharmaceuticals . Dr. Seifert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals .
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
James J. Gaul, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Robert T. Naismith, MD, FAAN	Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Christopher Giza, MD, FAAN	Dr. Giza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Network Speakers Bureau. Dr. Giza has stock in Highmark Interactive. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care. Dr. Giza has a non-compensated relationship as a Advisory Board with Major League Soccer that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Advisory Board with National Basketball Association that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Consultant with United States Soccer Federation that is relevant to AAN interests or activities. Dr. Giza has a non-compensated relationship as a Co-founder & Advisor with Symptomwise that is relevant to AAN interests or activities.
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Sergio Martinez-Yelamos, MD	No disclosure on file
Carmen Duran Herrera	No disclosure on file
	No disclosure on file
Cynthia Correll, MD	Dr. Correll has nothing to disclose.
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Christopher B. Traner, MD	Dr. Traner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuropace. Dr. Traner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Traner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Resident Matching Program .
Ryan Hubbard, MD	No disclosure on file
Rahul Chandak, MBBS	No disclosure on file
Amanda Persaud, MD	Dr. Persaud has nothing to disclose.
UDUAK WILLIAMS, MD	No disclosure on file
Bert B. Vargas, MD, FAAN	Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Oksana Suchowersky, MD, FAAN	Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Sharon E. Whiting, MBBS, FR	Dr. Whiting has nothing to disclose.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Guy A. Rouleau, MD, PhD, FAAN	Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Anup D. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with AAN that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with AAN Institute that is relevant to AAN interests or activities.
Marie Slegr, MD	No disclosure on file
Georgios M. Hadjigeorgiou, MD	No disclosure on file
Sheryl R. Haut, MD	Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iqvia.
Gretchen E. Tietjen, MD	An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Amanda C. Peltier, MD, MS	Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Lisa M. DeAngelis, MD, FAAN	Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Shannon L. Dean, MD	No disclosure on file
Margaret O. Johnson, MD	Dr. Johnson has nothing to disclose.
Sonia Magalhaes	No disclosure on file
Najayeb Alabdulraheem, MD	No disclosure on file
Changrui Xiao, MD	Dr. Xiao has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WIley. The institution of Dr. Xiao has received research support from NIH.
David Rezendes	No disclosure on file
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Tanya N. Turan, MD, FAAN	Dr. Turan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer/Merck. Dr. Turan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore Inc. Dr. Turan has received publishing royalties from a publication relating to health care. Dr. Turan has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Yaakov Stern, PhD	Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Jenny Y. Yu	No disclosure on file
Aaron L. Berkowitz, MD, PhD, FAAN	Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill ��ɫ��. Dr. Berkowitz has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received publishing royalties from a publication relating to health care. Dr. Berkowitz has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Clinical problem Solvers. Dr. Berkowitz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Thieme Publisher.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Yang Tang, MD	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Helena Bulka, DO	No disclosure on file
Michael Youssef, MD	Dr. Youssef has nothing to disclose.
Ahmad S. Siddiqi, MD	No disclosure on file
Kapil D. Sethi, MD, FRCP (UK), FAAN	Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Jan Schepel	No disclosure on file
Alexander C. Ou, MD	Dr. Ou has nothing to disclose.
Jonathan Krett, MD	Dr. Krett has nothing to disclose.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Freddi I. Segal-Gidan, PhD, PA	No disclosure on file
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Erin Longbrake, MD, PhD, FAAN	Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Longbrake has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ACTRIMS. Dr. Longbrake has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Longbrake has received research support from Genentech. The institution of Dr. Longbrake has received research support from NINDS K23. The institution of Dr. Longbrake has received research support from Robert Patterson Leet Trust. The institution of Dr. Longbrake has received research support from Biogen. The institution of Dr. Longbrake has received research support from National MS Society. The institution of Dr. Longbrake has received research support from Department of Defense. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Programmatic Review with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with National Institute of Health .
Paul M. Thompson, PhD	No disclosure on file
Vern C. Juel, MD, FAAN	Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Jeff Guptill, MD, FAAN	Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx.
Wolfgang Singer, MD, FAAN	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Vahid Shaygan Nejad, MD	Dr. Shaygan Nejad has nothing to disclose.
Frank S. Benesh, MD	Dr. Benesh has nothing to disclose.
Xiyan Yi, MD	Dr. Yi has nothing to disclose.
Muhammad Amjad Hameed, MD	No disclosure on file
Alyx B. Porter, MD, FAAN	Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Avi Setton, MD	No disclosure on file
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Charles A. Cape, MD, FAAN	No disclosure on file
James H. Bower, MD, MSc, FAAN	The institution of Dr. Bower has received research support from Abbvie.
Pritikanta Paul, MD	The institution of Dr. Paul has received research support from ZS Associates.
Oscar Fernandez	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Kenneth Leung, MD	Dr. Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals, Inc. Dr. Leung has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Muscular Dystrophy Association, Inc. Dr. Leung has received personal compensation in the range of $500-$4,999 for serving as a Speaker with California Neurology Society.
Bader A. Mohamed, Jr., MD	No disclosure on file
Setty M. Magana, MD, PhD	Dr. Magana has nothing to disclose.
Lily Chau, MD	Dr. Chau has nothing to disclose.
Aaron Desai, MD, MBBS	Dr. Desai has nothing to disclose.
Gabriel P. Lima, MD	Dr. Lima has received personal compensation for serving as an employee of Amgen Inc.
Mary Comeau	No disclosure on file
Peter D. Donofrio, MD, FAAN	No disclosure on file
Ilo Leppik, MD	Dr. Leppik has nothing to disclose.
George Grossberg, MD	Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Grossberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newron. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quince. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. The institution of Dr. Grossberg has received research support from NIA. The institution of Dr. Grossberg has received research support from Functional Neuromodulation .
Jonathan C. Calkwood, MD	Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bio. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Calkwood has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Calkwood has received research support from Sanofi. The institution of Dr. Calkwood has received research support from Novartis. The institution of Dr. Calkwood has received research support from Astra Zenica. The institution of Dr. Calkwood has received research support from TG Therapeutics. Dr. Calkwood has a non-compensated relationship as a Board of Trustees with National MS Society that is relevant to AAN interests or activities.
Stephanie Cosentino, PhD	Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for Frontotemporal Dementia. Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAGE Pharmaceuticals.
Maria J. Melanson, MD	No disclosure on file
Swathy Chandrashekhar, MD	Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Laura Dresser, MD	Dr. Dresser has nothing to disclose.
Nurose Karim, MD	Dr. Karim has nothing to disclose.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Katherine Longardner, MD	Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trisalus. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sirtex. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society of Interventional Oncology. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for France Foundation. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Varian. Dr. Longardner has received research support from NIH.
Yuri Maricich	No disclosure on file
Marco A. Diaz, MD	No disclosure on file
Hooman H. Beygi	No disclosure on file
Joseph I. Sirven, MD, FAAN	Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Justin T. Jordan, MD, MPH, FAAN	Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Helena C. Chui, MD	The institution of Dr. Chui has received research support from National Institute on Aging .
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Todd D. Rozen, MD, FAAN	No disclosure on file
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
Javier Gonzalez, MD	No disclosure on file
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Yesenia Enriquez-Gonzalez, MD	Dr. Enriquez-Gonzalez has nothing to disclose.
Sonja Chaparala, MD	No disclosure on file
Abdul W. Siddiqui, MD	No disclosure on file
Lili Velickovic Ostojic, MD	No disclosure on file
Jonathan Greco, DO	No disclosure on file
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Katherine B. Peters, MD, PhD, FAAN	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.
Sara E. Hocker, MD, FAAN	The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Kathrin LaFaver, MD, FAAN	Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to AAN interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to AAN interests or activities.
Heather Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Jodi Mueller-Hussein	Jodi Mueller-Hussein has nothing to disclose.
Douglas R. Polster, PhD	No disclosure on file
Elizabeth Joe, MD	The institution of Dr. Joe has received research support from NIH/NIA.
Keith Groshans, MD	Dr. Groshans has nothing to disclose.
Jeffrey B. Schachter, MD	Dr. Schachter has nothing to disclose.
Emily A. Ferenczi, MD, PhD	An immediate family member of Dr. Ferenczi has received personal compensation for serving as an employee of Cognito Therapeutics. An immediate family member of Dr. Ferenczi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. An immediate family member of Dr. Ferenczi has stock in Cognito Therapeutics. Dr. Ferenczi has stock in MapLight Therapeutics. The institution of Dr. Ferenczi has received research support from NIH. The institution of Dr. Ferenczi has received research support from Burroughs Wellcome Fund. Dr. Ferenczi has received intellectual property interests from a discovery or technology relating to health care. Dr. Ferenczi has received publishing royalties from a publication relating to health care.
Eduard Bercovici, MD	No disclosure on file
Fazeel M. Siddiqui, MD	No disclosure on file
Alexander Lerner	No disclosure on file
Talal M. Al-Harbi, MD, FAAN	Dr. Al-Harbi has nothing to disclose.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Dharampreet Singh, MD	No disclosure on file
Ostoja (Steve) Vucic, MBBS, FRACP	Prof. Vucic has a non-compensated relationship as a Member-Advisory Board with Biogen Idec Australia that is relevant to AAN interests or activities. Prof. Vucic has a non-compensated relationship as a Honorarium with Merkc Serono Ausralia that is relevant to AAN interests or activities.
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Jose J. Flores-Rivera, MD	Dr. Flores-Rivera has nothing to disclose.
Khalid Al Sherbini, MD	Dr. Al Sherbini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ceribell . Dr. Al Sherbini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Janaki Patel, MD	Dr. Patel has nothing to disclose.
Ali H. Abusrair, MD	Dr. Abusrair has nothing to disclose.
Matthew Remz, MD	Dr. Remz has nothing to disclose.
Lawrence I. Golbe, MD	Dr. Golbe has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aprinoia. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ferrer. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitochon. Dr. Golbe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Golbe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. Dr. Golbe has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Rossy Centre. Dr. Golbe has received intellectual property interests from a discovery or technology relating to health care. Dr. Golbe has received publishing royalties from a publication relating to health care. Dr. Golbe has a non-compensated relationship as a Chief Clinical Officer, Scientific Advisory Board Chair, Member of the Board of Directors, all as a volunteerd with CurePSP that is relevant to AAN interests or activities.
Jay A. Van Gerpen, MD, FAAN	No disclosure on file
Fredy J. Revilla, MD, FAAN	Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Ayoade M. Adebiyi, MD	No disclosure on file
Enrique Urrea-Mendoza, MD	Dr. Urrea-Mendoza has nothing to disclose.
Clifford Bechtold	No disclosure on file
Majid Kerolous, PharmD, MPH	No disclosure on file
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Delicias Munoz Garcia, MD	No disclosure on file
Zeeshan Ali, MD	No disclosure on file
Jason Chang, MD	Dr. Chang has nothing to disclose.
James M. Stankiewicz, MD, FAAN	Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Richard A. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Supreet K. Sahai, MD	Dr. Sahai has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG. Dr. Sahai has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint.
Tiffany H. Pike-Lee, MD	Dr. Pike-Lee has nothing to disclose.
Aakash S. Shetty, MD	Dr. Shetty has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Shetty has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Canada.
Syed A. Quadri, MD	Dr. Quadri has nothing to disclose.
Muhammad Taqi, MD	No disclosure on file
David M. Swope, MD	No disclosure on file
Morenikeji Komolafe, MD	Dr. Komolafe has nothing to disclose.
Jay-Jiguang Zhu, MD, PhD, FAAN	The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Ehtesham Khalid, MBBS	Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Adam L. Boxer, MD, PhD	An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Abu Nasar	No disclosure on file
Joseph Pleen, DO	Dr. Pleen has nothing to disclose.
Kelly L. Polito, MD	No disclosure on file
Livia Afonso, MD	No disclosure on file
Nikita Urval, MD	Dr. Urval has nothing to disclose.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
James R. Lupski, MD, PhD	Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Lupski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Genetics Center.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Mohammed Qureshi, MD	Dr. Qureshi has nothing to disclose.
Ajal Dave, MD	No disclosure on file
Dipali P. Nemade, MD	Dr. Nemade has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Chelsey Mcpheeters, PharmD	No disclosure on file
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Eugene L. Scharf, MD	The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Rahul D. Abhyankar, MD	No disclosure on file
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Miguel Angel Llaneza Gonzalez, MD	Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Yun Jik Park, MD	No disclosure on file
Martha Mulvey	No disclosure on file
Steven C. Cramer, MD, FAAN	Dr. Cramer has received personal compensation for serving as an employee of University of California. An immediate family member of Dr. Cramer has received personal compensation for serving as an employee of University of California. Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas, Alevian, Bayer, BlueRock Therapeutics, BrainQ, Constant Therapeutics, Medtronic, MicroTransponder, Myomo, Myrobalan, NeuroTrauma Sciences, Simcere, and TRCare. Dr. Cramer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MUSC. Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.
J. Clay Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.
Cumara B. O'Carroll, MD, FAAN	Dr. O'Carroll has nothing to disclose.
Ron E. Milo, MD, FAAN	Dr. Milo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck KGaA . Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brystol-Myers-Squibb . Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystol-Myers-Squibb.
Dulce M. Solar Sanchez	Dulce M. Solar Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS/SANOFI/BIOGEN/MERCK/ROCHE/ALMIRALL.
Marc Gotkine, MD	No disclosure on file
Sebastian Fridman, MD	Dr. Fridman has nothing to disclose.
Tracy Ander, DO	No disclosure on file
Zachary Vaslow, MD	No disclosure on file
Jessy Walia, MBBS	No disclosure on file
Manoj Goyal	No disclosure on file
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Matthew Blattner, MD	Dr. Blattner has nothing to disclose.
May A. Kim-Tenser, MD, MHA, FAHA	Dr. Kim-Tenser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi.
Kelly Harper	Ms. Harper has nothing to disclose.
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Danuel Snelgrove, MD	Dr. Snelgrove has nothing to disclose.
Joaquin Pena Martinez	Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellgene. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Flyn Kaida-Yip	No disclosure on file
Marion Oliver, MD	Dr. Oliver has nothing to disclose.
Julia Rybkina	No disclosure on file
Bernardo Cacho Diaz, MD, FAAN	Dr. Cacho Diaz has nothing to disclose.
Miguel Angel Hernandez Perez	Miguel Angel Hernandez Perez has nothing to disclose.
Pria Anand, MD	Dr. Anand has nothing to disclose.
Benjamin C. Cox, MD	The institution of Dr. Cox has received research support from American Epilepsy Society. The institution of Dr. Cox has received research support from Brain and Behavior Research Foundation.
Xi Li, MD	No disclosure on file
Ossama Khazaal, MD	No disclosure on file
Schiffon Wong	Schiffon Wong has received personal compensation for serving as an employee of EMD Serono.
Luke Chung	Luke Chung has received personal compensation for serving as an employee of Sanofi Genzyme. Luke Chung has received stock or an ownership interest from Sanofi Genzyme.
Michael Erb	No disclosure on file
Andrew R. Sas, MD, PhD	Dr. Sas has nothing to disclose.
Jiaying Zhang, MD	Dr. Zhang has nothing to disclose.
Madalina Chirieac, MD	No disclosure on file
Cheran Elangovan, MD	Dr. Elangovan has nothing to disclose.
Laurie Robak, MD, PhD	No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Joachim M. Baehring, MD, FAAN	Dr. Baehring has nothing to disclose.
Andres M. Villa, MD	Dr. Villa has nothing to disclose.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Wei Liu, MD	Dr. Liu has nothing to disclose.
Adrian Laxton	No disclosure on file
Holger Albrecht	No disclosure on file
Yasmeen Rauf, MBBS	Dr. Rauf has nothing to disclose.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Glen M. Doniger, PhD	No disclosure on file
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Sana Somani, MD, MBBS	Dr. Somani has nothing to disclose.
Sergio I. Valdes-Ferrer, MD, PhD	No disclosure on file
Nada A. Alyousha, MD	No disclosure on file
Sushma Kola, MD	Dr. Kola has nothing to disclose.
Akihiro Ueda	No disclosure on file
Bernadette Kalman, MD, PhD, Dsc, FAAN, FAAN	No disclosure on file
Byung-Jo Kim	No disclosure on file
John A. Lincoln, MD, PhD	The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
James F. Burke, MD	Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
Jeffrey S. Kutcher, MD, FAAN	Dr. Kutcher has nothing to disclose.
Marcello A. Oliveira	No disclosure on file
Cynthia A. Welsh, MD	Dr. Welsh has received intellectual property interests from a publication relating to health care.
Michael L. Palm, MD, FAAN	Dr. Palm has received personal compensation in the range of $0-$499 for serving as a Member of the UCNS Accreditation Council with United Council for Neurologic Subspecialties.
Michelle H. Leppert, MD	Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of American Heart Association. The institution of Dr. Leppert has received research support from Colorado Clinical and Translational Sciences Institute. The institution of Dr. Leppert has received research support from American Heart Association. Dr. Leppert has a non-compensated relationship as a Chair with Colorado Stroke Advisory Board that is relevant to AAN interests or activities. Dr. Leppert has a non-compensated relationship as a Early Career Editorial Board with Journal of the American Heart Association that is relevant to AAN interests or activities. Dr. Leppert has a non-compensated relationship as a Neurohospitalist Section Editor with Stroke that is relevant to AAN interests or activities.
Walaa Mohammed, Jr., MD	No disclosure on file
Susie Y. Huang, MD, PhD	Dr. Huang has received personal compensation in the range of $0-$499 for serving as a Consultant for Siemens Healthineers. The institution of Dr. Huang has received research support from Siemens Healthineers. The institution of Dr. Huang has received research support from Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School.
Robert Watson, Jr.	Robert Watson Jr. has a non-compensated relationship as a Chair with American Board of Magnetic Resonance Safety that is relevant to AAN interests or activities.
Mohamad Walid Al Sous, MD	No disclosure on file
Jeeyoung Oh, MD, PhD	Dr. Oh has nothing to disclose.
Allison Hoynes	No disclosure on file
Micah Etter, MD	Dr. Etter has nothing to disclose.
Joseph T Nguyen	Joseph T Nguyen has nothing to disclose.
Chandrasekhar Kasibhatla	No disclosure on file
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Rashi K. Krishnan, MD	No disclosure on file
Christina Reynolds	No disclosure on file
Christina Cramer	No disclosure on file
Matthias Meergans	No disclosure on file
Maria Kataki, MD, PhD, FAAN	No disclosure on file
Christine Holmstedt, DO	The institution of Dr. Holmstedt has received research support from NIH. The institution of Dr. Holmstedt has received research support from Patient-Centered Outcomes Research Institute.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Veronica Rivas	Veronica Rivas has nothing to disclose.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Kerri S. Remmel, MD, PhD	Dr. Remmel has nothing to disclose.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Matthew D. Holtkamp, DO	Dr. Holtkamp has nothing to disclose.
Oana M. Dumitrascu, MD, FAAN	Dr. Dumitrascu has nothing to disclose.
Nicki Niemann, MD	No disclosure on file
Sarah Clark	No disclosure on file
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Michael Popovich, MD	Dr. Popovich has nothing to disclose.
Edward J. Wild, MBBS, PhD, MRCP	Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teitur Trophics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Remix Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vico Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HDBuzz (a registered non-profit). The institution of Dr. Wild has received research support from CHDI Foundation (non-profit). The institution of Dr. Wild has received research support from Hoffman La Roche Ltd.
Barbara C. Jobst, MD, PhD, FAAN	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Andrei V. Alexandrov, MD	The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Douglas W. Scharre, MD, FAAN	Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Viviana I. Orozco, MD	No disclosure on file
Isabel Alfradique-Dunham, MD	No disclosure on file
Mohammad Hajighasemi-Ossareh, MD	No disclosure on file
Aaron A. Daley, MD	No disclosure on file
Nasima D. Shadbehr, DO	Dr. Shadbehr has nothing to disclose.
Christine Lu, MD	No disclosure on file
Hanim Kwon, MD	No disclosure on file
Omar Isaac Castillo-García	No disclosure on file
Ana Lopez Real	Ana Lopez Real has received personal compensation in the range of $0-$499 for serving as a Consultant for Janssen. Ana Lopez Real has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi Genzyme. Ana Lopez Real has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Ana Lopez Real has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Alla Shifrin, MD	Dr. Shifrin has nothing to disclose.
Jane G. Morris, MD	Dr. Morris has nothing to disclose.
Mohammad Shafie, MD	Dr. Shafie has nothing to disclose.
Rohan Mathur, MD	Dr. Mathur has nothing to disclose.
George J. Hutton, MD, FAAN	Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Alfredo Rodriguez Antiguedad, MD	Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for NOVARTIS. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MERCK.
Siddharth Gupta, MD	No disclosure on file
Ikuko Aiba	Ikuko Aiba has nothing to disclose.
Joshua Trujeque	No disclosure on file
Alit Bhatt	Alit Bhatt has nothing to disclose.
Daniel G. Larriviere, MD, JD, FAAN	Dr. Larriviere has nothing to disclose.
Daniel J. MacGowan, MD, FAAN	No disclosure on file
W. O. Tobin, PhD, MBBCh, BAO, FAAN	Dr. Tobin has received publishing royalties from a publication relating to health care.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Adolfo Ramirez Zamora, MD	Dr. Ramirez Zamora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel therapeutics. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPacs. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota Inc. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Dr. Ramirez Zamora has received research support from Parkinsons Foundation.
Teresa V. Corona Vazquez, MD	Dr. Corona Vazquez has received research support from Consejo Nacional de Ciencia y Tecnologia.
Islam Zaydan, MD	No disclosure on file
Ariel L. Miller, MD, PhD	Dr. Miller has nothing to disclose.
Ivo W. Tremont, MD, FAAN	Dr. Tremont has nothing to disclose.
Meeryo Choe, MD, FAAN	Dr. Choe has received personal compensation for serving as an employee of Harvard-Westlake School. Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Ekokobe Fonkem, DO	Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Nitin Goyal, MD	No disclosure on file
Stephen A. Johnson, MD	The institution of Dr. Johnson has received research support from ALS Association.
Christian Cornelissen	No disclosure on file
Virginia Meca Lallana	Virginia Meca Lallana has nothing to disclose.
Fang Zhang	No disclosure on file
Aliyah R. Snyder, PhD	Dr. Snyder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Neuro Company.
Shahrzad Deliran, MD	No disclosure on file
Harvey W. Buchsbaum, MD	No disclosure on file
Noa Sheikin, MD	No disclosure on file
Joseph T. Dye, PhD	No disclosure on file
Marjory S. Levey, PhD	No disclosure on file
Joyutpal Das, MBBS	Dr. Das has nothing to disclose.
Darshana Siresena	Darshana Siresena has nothing to disclose.
Anisha Maheshwari	No disclosure on file
Monica Mejia-Acosta, MD	No disclosure on file
Anthony T. Yachnis, MD	No disclosure on file
Tracy T. Batchelor, MD, MPH	Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Isabelle Berry, MD, PhD	No disclosure on file
Ajeet S. Sodhi, MD	No disclosure on file
George S. Selas, MD	No disclosure on file
Amanda H. Croxton, DO	No disclosure on file
Rachel Colman, MD	No disclosure on file
Roy Alcalay, MD	Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Rene Elkin, MD	No disclosure on file
Angeles Schteinschnaider, MD	No disclosure on file
Taylor Haight, MD	Dr. Haight has nothing to disclose.
Amy Ferng, MD	No disclosure on file
Shreya Nayak, MD	Dr. Nayak has nothing to disclose.
Solomon Ambe, MBBS	Dr. Ambe has nothing to disclose.
Riwanti Estiasari	No disclosure on file
Elena Alvarez Rodriguez	Elena Alvarez Rodriguez has nothing to disclose.
Nagaraj Sanchitha Honganur	No disclosure on file
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ�� (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Gregory Fuller, MD, PhD	Dr. Fuller has nothing to disclose.
Diana Goodman, MD	Dr. Goodman has received personal compensation for serving as an employee of Maine Medical Partners. An immediate family member of Dr. Goodman has received personal compensation for serving as an employee of Maine Medical Partners.
Ashwaq Alshahrani, MD	No disclosure on file
Tushar Bajaj	No disclosure on file
Sarah B. Vargas, Jr., MD	No disclosure on file
Marina K. Girgis	No disclosure on file
Dhiren R. Patel, MBBS	No disclosure on file
Jiraporn Jitprapaikulsan, MD	Dr. Jitprapaikulsan has nothing to disclose.
Lisa K. Peterson, PhD	Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to AAN interests or activities.
Bryan K. Ho, MD	No disclosure on file
William D. Walters, MD	No disclosure on file
Abdullah Alkutbi, MD	No disclosure on file
Paul Wacnik	No disclosure on file
Niloofar Yari, MD	Dr. Yari has nothing to disclose.
David Rahimian, MD	No disclosure on file
Michaela H. Schwaiblmair	No disclosure on file
Laura Popper, MD	Dr. Popper has received personal compensation for serving as an employee of Mapi Pharma.
Shlomo Flechter, MD, FAAN	Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma.
R.M.M. Hupperts, MD	No disclosure on file
Bruno C. Musch, MD	No disclosure on file
Steven P. Sparagana, MD, FAAN	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Ritvij Bowry, MD	Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Xin Xin Yu, MD	No disclosure on file
Rodica Di Lorenzo, MD	Dr. Di Lorenzo has nothing to disclose.
Arnavaz Hajizadeh Barfejani	No disclosure on file
Blake E. Senay, DO	No disclosure on file
Elizabeth R. Gerstner, MD	Dr. Gerstner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Midatech. Dr. Gerstner has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Gerstner Family Foundation. The institution of Dr. Gerstner has received research support from NCI.
J. Theodore Phillips, MD, PhD, FAAN	No disclosure on file
Gabriel Bucurescu, MD	No disclosure on file
Lindsay K. Blair, MSN	Ms. Blair has nothing to disclose.
Mohamad Orabi, MD	No disclosure on file
Brian Nahed	No disclosure on file
Priyanka Samal	Ms. Samal has nothing to disclose.
Sona Mistry, MD, MBBS	No disclosure on file
Young-Min Lim, MD	Dr. Lim has nothing to disclose.
Jonathan D. Campbell, PhD	Dr. Campbell has received personal compensation for serving as an employee of Institute for Clinical and Economic Review.
Paula P. Warren, MD	No disclosure on file
Ratna K. Bhavaraju-Sanka, MD, FAAN	Dr. Bhavaraju-Sanka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhavaraju-Sanka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Seol-Hee Baek, MD	Dr. Baek has nothing to disclose.
Keith Morneau	No disclosure on file
Doreen Ho, MD	Dr. Ho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
David Eidelberg, MD, FAAN	Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Rabia Malik, MD	Dr. Malik has nothing to disclose.
Brian Sansoucy	No disclosure on file
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Kathleen Poston, MD, FAAN	Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
David Brassat, MD, PhD	No disclosure on file
Ankush Bhatia, MD	No disclosure on file
David Q. Mao, MD	Dr. Mao has nothing to disclose.
Daniel Golan, MD	No disclosure on file
Amy Goldberger, PhD	No disclosure on file
Mina Lobbous, MD	Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Pharmaceuticals . Dr. Lobbous has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Pharmaceuticals . Dr. Lobbous has received publishing royalties from a publication relating to health care.
Tijil Agarwal, MD	Dr. Agarwal has nothing to disclose.
Briana P. Meyer	No disclosure on file
Aimee S. Payne, MD, PhD	No disclosure on file
Megan B. Edwards, DO	Dr. Edwards has nothing to disclose.
Daniel Anderson, DO	No disclosure on file
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Bradley N. Howell, MD	Dr. Howell has nothing to disclose.
Kishan Patel, MD	No disclosure on file
ROBERTA ARB SABA RODRIGUES PINTO	No disclosure on file
Gabriela Colpo	Gabriela Colpo has nothing to disclose.
Tulika Ranjan, MD	No disclosure on file
Karissa Gable, MD, FAAN	Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accordant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenca. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols . Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for annexon. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Navid Manouchehri, MD	Navid Manouchehri has nothing to disclose.
Joel N. Phillips, DO, FAAN	Dr. Phillips has nothing to disclose.
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Lee H. Schwamm, MD, FAAN	Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime ��ɫ��. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
Goutam Gangopadhyay	No disclosure on file
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Angeline S. Andrew, PhD	No disclosure on file
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Philippe Truffinet, MD	Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Angelo Ghezzi, MD	No disclosure on file
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Marc I. Chimowitz, MD	An immediate family member of Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gore. Dr. Chimowitz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo Inc. The institution of Dr. Chimowitz has received research support from NIH.
Paul S. Fishman, MD, PhD	No disclosure on file
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Ann D. Bass, MD	Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Jose A. Carrillo, MD	No disclosure on file
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Vibhor Krishna	No disclosure on file
Shervin Badihian, MD	Dr. Badihian has nothing to disclose.
John G. Boyd, MD	No disclosure on file
Joseph M. Ferrara, MD, FAAN	No disclosure on file
Angela N. Hays Shapshak, MD	The institution of Dr. Hays Shapshak has received research support from NIH/NINDS. Dr. Hays Shapshak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Department of Justice.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Steven J. Cavalier, MD, FAAN	No disclosure on file
Jeffrey L. Cummings, MD, FAAN	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Lara K. Ronan, MD, FAAN	No disclosure on file
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Eugenia Marzo	No disclosure on file
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Kevin P. Becker, MD, PhD	No disclosure on file
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Ning S. Yang, MD	Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Yang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Yang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Sushma R. Yerram, MD	Dr. Yerram has nothing to disclose.
Johanna Tuunainen	No disclosure on file
Luca Prosperini, MD	No disclosure on file
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Mary Kelley, DO	Dr. Kelley has nothing to disclose.
Madison B. Harris, OT	Dr. Harris has nothing to disclose.
Mandy Koop	No disclosure on file
Adrian Marchidann, MD	Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Karen Blitz-Shabbir, DO	No disclosure on file
Susanne Ostrowitzki, MD, PhD	No disclosure on file
Julio A. Chalela, MD	Dr. Chalela has nothing to disclose.
Adriana B. Conforto, MD, PhD	Dr. Conforto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Conforto has received personal compensation in the range of $0-$499 for serving as a Consultant for Eurofarma. Dr. Conforto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HCX. The institution of Dr. Conforto has received research support from CNPq. Dr. Conforto has received research support from CNPq. Dr. Conforto has received publishing royalties from a publication relating to health care. Dr. Conforto has received personal compensation in the range of $5,000-$9,999 for serving as a Travel grant recipient with FAPESP.
Mohan Kottapally, MD	Dr. Kottapally has nothing to disclose.
James Crispo	No disclosure on file
Daniel P. Cahill, MD, PhD	Daniel P. Cahill, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Advise Connect Inspire. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for German Accelerator. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Incephalo. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.
Eun Bin Cho, MD	No disclosure on file
Damiano Baroncini	No disclosure on file
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with ��ɫ��. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Patrick M. Kwon, MD	Dr. Kwon has nothing to disclose.
Cassandra P. Cross, MD	No disclosure on file
Saurabh Singhal, MD, MBBS	Dr. Singhal has nothing to disclose.
Simon M. Bell, MBChB, MRCP	No disclosure on file
Mahsa Khayat-Khoei, MD	The institution of Dr. Khayat-Khoei has received research support from The National MS Society of America, for Fellowship Award.
Matthew Sumicad	No disclosure on file
Kevin Bigaut	Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Barbara Voetsch, MD, PhD	The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to AAN interests or activities.
John D. Steffens, MD	Dr. Steffens has nothing to disclose.
Susan M. Staugaitis, MD, PhD	No disclosure on file
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Buchhalter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona.
Carlayne E. Jackson, MD, FAAN	Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Volker Limmroth, MD, PhD	No disclosure on file
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Nathaniel J. Mohney, MD	The institution of Dr. Mohney has received research support from NIH.
Sandro J. Corti, MD	No disclosure on file
Ibrahim Migdady, MD	Dr. Migdady has nothing to disclose.
Bhavika Kakadia, DO	Dr. Kakadia has nothing to disclose.
Lisa M. Stropp, MD	No disclosure on file
Natalie Neale, MD	Dr. Neale has nothing to disclose.
Helen Bronte-Stewart, MD, MSE	Dr. Bronte-Stewart has stock in QDG Health. Dr. Bronte-Stewart has received intellectual property interests from a discovery or technology relating to health care.
Helen C. Lin, MD	Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
David Cella, PhD	No disclosure on file
Talin Babikian	Talin Babikian has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Various. The institution of Talin Babikian has received research support from NINDS.
Michelle Voss	No disclosure on file
Eun Hee Sohn	No disclosure on file
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Christopher T. Whitlow, MD	Dr. Whitlow has nothing to disclose.
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Matthew J. Burke, MD, FRCPC	Dr. Burke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Burn Tucker Lachaîne. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Lerners LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Blakes LLP. Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Carroll Heyd Chown LLP. Dr. Burke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Caza Saikaley LLP. The institution of Dr. Burke has received research support from Liu Fu Yu Charity Foundation.
Crystal J. Yeo, MD, PhD	Dr. Yeo has nothing to disclose.
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Francisco E. Gomez III, MD	No disclosure on file
Erika Shelton	No disclosure on file
Nebahat Tasdemir, MD	No disclosure on file
Fethi Idiman	No disclosure on file
Carey A. Wilson, MD	No disclosure on file
Colleen B. Murphy, MD	No disclosure on file
Hebatalla Elhusseiny, MD	Dr. Elhusseiny has nothing to disclose.
Ryan Heslin	No disclosure on file
Kristen Malloy	No disclosure on file
Eva Havrdova, MD	Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Waleed Ahmed Khoja, MD	Dr. Khoja has nothing to disclose.
Sidney Oparah, MD	Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . Dr. Oparah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MICRO LABS.
Ka-wai G. Ho, MD	No disclosure on file
Shannon White, NP	No disclosure on file
David Geldmacher, MD	Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Premier, Inc. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Author with ��ɫ��.
Nicholas Metrus, MD	Dr. Metrus has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for dotdash / Verywell Health.
Shivika Chandra, MD, FAAN	The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in ��ɫ�� Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Derya Kaya	No disclosure on file
Pradeep C. Bollu, MD	Dr. Bollu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Jesse Fishman, PharmD	No disclosure on file
Iris V. Marin Collazo, MD	Dr. Marin Collazo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG.
Gilles Edan	Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Erica Marini	No disclosure on file
David Blas-Boria, MD, FAAN	Dr. Blas-Boria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure.
Andrew Lin, MD	No disclosure on file
Austin T. Momii, MD	Dr. Momii has nothing to disclose.
Boris Kandinov	No disclosure on file
Manoj S. Nair, MD	No disclosure on file
Peter Feldman	No disclosure on file
Pieter Janssen	No disclosure on file
Atanu Biswas, MD	Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for INTAS Pharmaceuticals. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for lupin Limited. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkem Laboratories. Dr. Biswas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Torrent Pharmaceuticals.
Judea Wiggins, MD	Dr. Wiggins has nothing to disclose.
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities.
Christa O'hana S. Nobleza, MD	Dr. Nobleza has nothing to disclose.
Neepa J. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernius Pharmaceuticals. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Shruti M. Raja, MD	Dr. Raja has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics, Inc..
Amanda Pennington, MD	No disclosure on file
John Edwards	No disclosure on file
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Alireza Atri, MD, PhD	Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Atri has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lunbeck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. The institution of Dr. Atri has received research support from National Institute of Aging (NIA). The institution of Dr. Atri has received research support from AZ Department of Health Services. The institution of Dr. Atri has received research support from Gates Ventures. The institution of Dr. Atri has received research support from Multiple companies, universities & consortia for contracted clinical trials to institution. The institution of Dr. Atri has received research support from Washington University in St. Louis. The institution of Dr. Atri has received research support from Foundation for NIH. The institution of Dr. Atri has received research support from ACTC/NIH. Dr. Atri has received publishing royalties from a publication relating to health care.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Pravin Khemani, MD, FAAN	Dr. Khemani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Lekhjung Thapa, MD, DM-Neurology	No disclosure on file
Susanna S. Kwok	No disclosure on file
Mario Altikes Hazzan, MD	No disclosure on file
Erin D'Agostino, MD	Dr. D'Agostino has nothing to disclose.
Sulochana Ghimire, RN	No disclosure on file
Janell Routh	No disclosure on file
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Erik Uhlmann, MD	Dr. Uhlmann has nothing to disclose.
Albert Jin, MD	No disclosure on file
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Simon Broadley, PhD, FRACP	The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC.
Natalya Shneyder, MD	Dr. Shneyder has nothing to disclose.
Marcus Ng, MD	The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Francis M. Filloux, MD	Dr. Filloux has nothing to disclose.
Jesus E. Pina-Garza, MD	Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Ho Jin Kim, MD	Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
Betul B. Gundogdu, MD	Dr. Gundogdu has nothing to disclose.
Michael Kaplitt, MD	No disclosure on file
Ashley M. Roque, MD	No disclosure on file
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Jaishri Blakeley, MD, FAAN	Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Sushma Bellamkonda, MD	No disclosure on file
Hyelim Lee, MD	No disclosure on file
Krithika Rajagopalan	No disclosure on file
Mohammad Ridha, MD	No disclosure on file
Ergun Y. Uc, MD	An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Christopher Calder, MD, PhD, FAAN	No disclosure on file
Dana S. Cooper, MD	No disclosure on file
Sanjida Chowdhury, MBBS, MSc, MRCP	No disclosure on file
Sa-Yoon Kang, MD	No disclosure on file
Alexey Boyko, MD, PhD	No disclosure on file
Laurence E. Walsh, MD	No disclosure on file
Kiyonobu Komai, MD	Dr. Komai has nothing to disclose.
Joe Verghese, MD, FAAN	Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Garrett E. Alexander, MD	No disclosure on file
Kauroon M. Darya, DO	No disclosure on file
Varsha Prabhakar, BA	No disclosure on file
Kelly Bertram, MBBS	No disclosure on file
Nathan S. Farkas, MD	No disclosure on file
Anusha Boyanpally, MBBS	No disclosure on file
Benjamin Zusman, MD	Mr. Zusman has received research support from University of Pittsburgh .
Durjoy Lahiri, MD, DM	Dr. Lahiri has nothing to disclose.
Aikaterini Kompoliti, MD, FAAN	Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kompoliti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. Dr. Kompoliti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Kompoliti has received research support from Emalex. Dr. Kompoliti has received research support from TEVA. Dr. Kompoliti has received research support from Theravance. Dr. Kompoliti has received research support from Ipsen. Dr. Kompoliti has received research support from Theravance.
Warren Darling	No disclosure on file
Kwang-Kuk Kim, MD	No disclosure on file
Karthikeyan M. Arcot, MD	No disclosure on file
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Marissa C. Natelson Love, MD, FAAN	Dr. Natelson Love has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium Pharma. Dr. Natelson Love has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Natelson Love has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burns, Cunningham & Mackey. The institution of Dr. Natelson Love has received research support from Eisai. The institution of Dr. Natelson Love has received research support from Eli Lilly. The institution of Dr. Natelson Love has received research support from Janssen. The institution of Dr. Natelson Love has received research support from Vaccinex. The institution of Dr. Natelson Love has received research support from Ono Pharmaceuticals.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Sean C. Rose, MD, FAAN	Dr. Rose has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Summit Experts. The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Christian Grommes, MD	Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Jessica Frau	No disclosure on file
Kevin Bickart, MD, PhD	Dr. Bickart has nothing to disclose.
Dominique L. Dive, MD	No disclosure on file
Luis E. Bello-Espinosa, MD, FAAN	Dr. Bello-Espinosa has nothing to disclose.
Bruce R. Rosen, MD	No disclosure on file
Jan N. Lycke, MD	Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
Teena Shetty, MD, FAAN	Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Marium Jamil, MBBS	No disclosure on file
Mihaela Nica	No disclosure on file
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
George Howard, PhD	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Lisa Hobson-Webb, MD, FAAN	Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Hobson-Webb has received research support from Abcuro. The institution of Dr. Hobson-Webb has received research support from Avidity. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Talk - not speaker bureau with Takeda. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Talk - not speaker bureau with CSL Behring.
G. Rees Cosgrove, MD, FRCS(C)	No disclosure on file
Kevin M. Barrett, MD, FAAN	Dr. Barrett has nothing to disclose.
Jessica E. Rexach, MD, PhD	Dr. Rexach has nothing to disclose.
Noor A. Pirzada, MD, FAAN	Dr. Pirzada has nothing to disclose.
Claudio G. Mazia, MD	No disclosure on file
David Hojnacki, MD, FAAN	Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Marko Petrovic, MD	Dr. Petrovic has nothing to disclose.
Priyadarshee Patel, MD	No disclosure on file
Fernando Torres	Fernando Torres has nothing to disclose.
Donald B. Sanders, MD, FAAN	Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Michael I. Shevell, MD, FAAN	Dr. Shevell has nothing to disclose.
Jessica K. Alexander, PhD	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Kathryn S. Nevel, MD	Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Francesca Sangalli	No disclosure on file
Amy E. Sanders, MD, FAAN	Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adlarity. Dr. Sanders has a non-compensated relationship as a Medical and Scientific Advisory Board with Alzheimer's Association (CT Chapter) that is relevant to AAN interests or activities. Dr. Sanders has a non-compensated relationship as a Board Member with UCNS that is relevant to AAN interests or activities.
Nabil M. Biary, MD, FAAN	No disclosure on file
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
Mitchell M. Danesh, MD	Dr. Danesh has nothing to disclose.
Stanley Tuhrim, MD	No disclosure on file
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
David Schiff, MD, FAAN	Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
Aisha M. Malik, MD	No disclosure on file
Safwan S. Jaradeh, MD, FAAN	Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Daniela Pohl, MD	No disclosure on file
Rebecca L. Sugg, MD, FAAN	Dr. Sugg has nothing to disclose.
Awss Zidan, MD	An immediate family member of Dr. Zidan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ruham Nasany MD.
Scott L. Silliman, MD	Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Robert Arbuckle, MD	No disclosure on file
Vanessa Merker	The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network.
Thomas Duginski, MD	No disclosure on file
Matthew J. Mandel, MD	Dr. Mandel has received personal compensation for serving as an employee of EMD Serono.
Sneha Jacob, MD	Dr. Jacob has nothing to disclose.
Amir Besharat, DO	Dr. Besharat has nothing to disclose.
Laura J Weinkle, MS	No disclosure on file
Shreya Shah, MD	Dr. Shah has nothing to disclose.
Claudia Moy, PhD	Claudia Moy, PhD has nothing to disclose.
Guillaume Sebire	No disclosure on file
Rebecca L. Hurst, MD	Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Adeniyi Fisayo, MD	Dr. Fisayo has nothing to disclose.
Premkumar Nattanmai Chandrasekaran, MD	Dr. Nattanmai Chandrasekaran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Jennifer J. Manly, PhD	The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Alasdair Coles, MD, PhD	Dr. Coles has nothing to disclose.
Rajan R. Gadhia, MD	Dr. Gadhia has nothing to disclose.
Angeliki Tsapanou, PhD	Dr. Tsapanou has nothing to disclose.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Valeria Alvarez	No disclosure on file
Francisco Javier Ricart	Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
Mariana Suarez	No disclosure on file
Xiao-Tang Kong, MD, PhD	Dr. Kong has nothing to disclose.
Dana L. Vanino, DO	Dr. Vanino has nothing to disclose.
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Sven Schippling	No disclosure on file
Michael Grundman, MD, MPH	Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
Jennifer L. Clarke, MD, MPH	The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Clarke has received research support from Agios. The institution of Dr. Clarke has received research support from Servier. The institution of Dr. Clarke has received research support from Merck.
Saeed A. Bohlega, MD	No disclosure on file
Anneke Van Der Walt, MD	Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Guy Laureys, MD, PhD	The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Soha Sadeghikhah, MD	Dr. Sadeghikhah has nothing to disclose.
Wan Tsong	No disclosure on file
Ankita Ghosh, MD	Dr. Ghosh has nothing to disclose.
Konstantin Senkevich, MD	The institution of Dr. Senkevich has received research support from MJFF. Dr. Senkevich has received research support from HBHL. Dr. Senkevich has received research support from FRQS.
Gene H. Barnett, MD	Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris Medical.
Taofiki A. Sunmonu, MD, FAAN	Dr. Sunmonu has nothing to disclose.
Mohammad Fouladvand, MD	No disclosure on file
Lydia Sharp, MD	The institution of Dr. Sharp has received research support from McNair Foundation. The institution of Dr. Sharp has received research support from ALS Association.
Juan Pablo Ospina Botero, MD	No disclosure on file
Andres De Leon, MD	Dr. De Leon Benedetti has nothing to disclose.
Mayara T. Graciani, MD	No disclosure on file
Christina Palmese	Christina Palmese has nothing to disclose.
Marco Onofrj, MD	Dr. Onofrj has nothing to disclose.
Jennie W. Taylor, MD	Dr. Taylor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. The institution of Dr. Taylor has received research support from BMS. The institution of Dr. Taylor has received research support from Servier. The institution of Dr. Taylor has received research support from Navio. Dr. Taylor has received research support from University of Colorado. Dr. Taylor has received research support from Mt Sinai University . Dr. Taylor has received publishing royalties from a publication relating to health care.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Robert Laforce, Jr., MD, PhD	Dr. Laforce has nothing to disclose.
Natalie P. Witek, MD	Dr. Witek has nothing to disclose.
Harvey S. Singer, MD, FAAN	No disclosure on file
Christopher C. LaGanke, MD	Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Sat Dev Batish, PhD, FAAN	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Rany A. Aburashed, DO	No disclosure on file
Agnes Kowalska, MD	Dr. Kowalska has nothing to disclose.
Ji-Yeoun Yoo, MD	Dr. Yoo has received publishing royalties from a publication relating to health care.
Pamela A. McCombe, MD	Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. The institution of Dr. McCombe has received research support from Motor Neurone Disease Resaerch Institute of Australia.
Francisco J. Varela, MD	Dr. Varela has nothing to disclose.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Anh-Thu N. Vu, MD, MS	Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ScholarRx.
Aashrai S. Gudlavalleti, MBBS	Dr. Gudlavalleti has nothing to disclose.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Kevin Bui, MD	No disclosure on file
Justine E. Cormier, MD	Dr. Cormier has nothing to disclose.
Laura Clarke, MBBS	Dr. Clarke has nothing to disclose.
Adreesh Mukherjee, MD	Dr. Mukherjee has nothing to disclose.
Yonatan Serlin, MD	Dr. Serlin has nothing to disclose.
Sidney Hinds, MD, FAAN	An immediate family member of Dr. Hinds has received personal compensation for serving as an employee of Henry Jackson Foundation. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otolith. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ICON. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Conafay Group. Dr. Hinds has received research support from Uniformed Service University. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Panel member with Congressionally Directed Medical Research Program. Dr. Hinds has a non-compensated relationship as a Ex Offcio Board member with NINDS/NANDS that is relevant to AAN interests or activities.
Jasmin T. Jo, MD	Dr. Jo has nothing to disclose.
Elanagan Nagarajan, MD	Dr. Nagarajan has nothing to disclose.
Mohammad Ghatali, MD	Dr. Ghatali has nothing to disclose.
Royce Sumayo	No disclosure on file
Margaret S. Lee, PhD	No disclosure on file
Prabhu D. Emmady, MD, MBA	No disclosure on file
Syed F. Ali, MD	No disclosure on file
Chen Zhao, MD	Dr. Zhao has nothing to disclose.
Christine Saint-Martin	No disclosure on file
Antonio Bertolotto, MD, FAAN	Dr. Bertolotto has nothing to disclose.
John R. Rinker II, MD, BA	Dr. Rinker has nothing to disclose.
Shoshannah Rubin	No disclosure on file
Jaime Olivas	No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Neda Zarghami Esfahani, MD	Dr. Zarghami Esfahani has nothing to disclose.
Nirav Sanghani, MBBS	Dr. Sanghani has nothing to disclose.
James J. Sejvar, MD, FAAN	Dr. Sejvar has nothing to disclose.
Lauren Jackson, MD	Dr. Jackson has nothing to disclose.
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Georgia D. Montouris, MD	No disclosure on file
David H. Margolin, MD, PhD	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Joel I. Shenker, MD, PhD, FAAN	Dr. Shenker has received personal compensation for serving as an employee of R3 continuum. Dr. Shenker has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for attorneys.
Scott R. Plotkin, MD, PhD, FAAN	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Virginia J. Howard, PhD	The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Harold P. Adams, Jr., MD, FAAN	The institution of Dr. Adams has received research support from NINDS.
Colin B. Van Orman, MD	No disclosure on file
Sahil Gupta, MD	Dr. Gupta has nothing to disclose.
Shreyas Gangadhara, MD, FAAN	Dr. Gangadhara has nothing to disclose.
Phillip A. Low, MD, FAAN	Dr. Low has nothing to disclose.
Jihad S. Inshasi, MD, MBBS, FAAN	Dr. Inshasi has nothing to disclose.
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Pietro Iaffaldano	No disclosure on file
Meagan D. Seay, DO	Dr. Seay has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various attorneys.
Ronald C. Siu, MBBS	No disclosure on file
Pradeep Kumbham, MD	Dr. Kumbham has nothing to disclose.
Brittany Wedeman	No disclosure on file
Richard Leigh-Pemberton, MD	No disclosure on file
Jennifer Guo	No disclosure on file
Julie Aldridge, MS	Ms. Aldridge has received personal compensation for serving as an employee of EMD Serono.
Philip Rosenbaum	Mr. Rosenbaum has received research support from Region IV Training Center.
Muhammad Afzal	No disclosure on file
Hassaan H. Bashir, MBBS	No disclosure on file
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Nicole Schupf, PhD, DrPH	No disclosure on file
Nazely Ashikian, MD	Dr. Ashikian has nothing to disclose.
Jenifer Voeks	Jenifer Voeks has nothing to disclose.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Zain Guduru, MD, FAAN	Dr. Guduru has nothing to disclose.
Cory J. Rice, MD	No disclosure on file
Shamik Shah, MBBS	Dr. Shah has nothing to disclose.
Philippine Dana Peralta, MD	No disclosure on file
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
MARIA JOSE MORENO JIMENEZ	No disclosure on file
Renee Nelson, MD	Dr. Nelson has nothing to disclose.
Ivan D. Carabenciov, MD	Dr. Carabenciov has nothing to disclose.
Peter Dechent	No disclosure on file
Mark Shiroishi	No disclosure on file
Michelle Shapiro, MD	Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Leah R. Hanson, PhD	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Maria Gaughan, MBBS	Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Fan Wu, PhD	No disclosure on file
Beatriz S. Haynes, MD	No disclosure on file
Bart Van de Warrenburg	No disclosure on file
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Julius Latorre, MD, FAAN	Dr. Latorre has nothing to disclose.
Rajeev Motiwala, MD, FAAN	Dr. Motiwala has nothing to disclose.
John F. De Groot, MD	An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Jeffrey M. Chavin, MD, FAAN	Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Andrew Chan	No disclosure on file
Jean Khoury, MD	Dr. Khoury has nothing to disclose.
Divya Arya, MD	Dr. Arya has nothing to disclose.
Michael D. Dreyer, MD	No disclosure on file
Nicholas A. Butowski, MD	No disclosure on file
Eliz H. Agopian, MD	Dr. Agopian has nothing to disclose.
Jean Christophe Corvol, MD	No disclosure on file
Tyler J. Story, PhD	No disclosure on file
Virginia A. Devonshire, MD	Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Antonio Carotenuto	Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Jeanne S. Teitelbaum, MD	No disclosure on file
Branko N. Huisa, MD	No disclosure on file
Anza B. Memon, MD, FAAN	Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Addie Patterson, DO	Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
S H. Subramony, MBBS, FAAN	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex.
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Daniela Bota, MD	No disclosure on file
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Yian Gu, PhD	The institution of Dr. Gu has received research support from NIH.
Dieter Haering	Dieter Haering has received personal compensation for serving as an employee of Novartis.
Herval Soares-Neto	No disclosure on file
Shashank Shekhar, MBBS	The institution of Dr. Shekhar has received research support from Sponsor Department of Health and Human Services. The institution of Dr. Shekhar has received research support from PockitDx.
Sarah Madani, MD	No disclosure on file
Claudio E. Rodriguez, MD	No disclosure on file
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
Yuan Kit Christopher Chua, MBBS	No disclosure on file
Yingkai Li, MD, PhD	Dr. Li has nothing to disclose.
Peter R. Camfield, MD	No disclosure on file
Mark-Victor Siwoski, MD	No disclosure on file
Shilpa Chaku, MD	No disclosure on file
John C. Greenert, MD	No disclosure on file
David O. Kamson, MD	The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund. The institution of Dr. Kamson has received research support from AACR. The institution of Dr. Kamson has received research support from Metavivor. The institution of Dr. Kamson has received research support from NIH.
Yosbelkys Martin Paez, MD	Dr. Martin Paez has nothing to disclose.
Faisal Rashid	No disclosure on file
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Franco Granella	Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Franco Granella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono.
Abdulaziz M. Al-Semari, MD	No disclosure on file
Laurence Martineau, MD	No disclosure on file
Joshua Santucci, MD	Dr. Santucci has nothing to disclose.
Jay Kinariwala, MD	Dr. Kinariwala has nothing to disclose.
Karan Tarasaria, MBBS	Dr. Tarasaria has nothing to disclose.
Leila Sellami, MD	Dr. Sellami has nothing to disclose.
Hammad Shaikh	No disclosure on file
Melissa Russo	No disclosure on file
Hamada H. Altalib, DO	The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
William J. Triggs, MD	No disclosure on file
Wei Ping Kay Ng, MD	Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
Cara E. Harth, MD, FAAN	Dr. Harth has received personal compensation in the range of $500-$4,999 for serving as a In-House Expert Reviewer with Academic Group.
Ayman E. Hassan, MD, FAAN	Dr. Hassan has nothing to disclose.
Sujan Teegala S. Reddy, MD	Dr. Reddy has nothing to disclose.
Erica McKenzie, MD	Dr. McKenzie has nothing to disclose.
Pratap R. Chand, MD, FRCP, FAAN	Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience.
Anna Khanna, MD	Dr. Khanna has nothing to disclose.
Ayse Altintas, MD	Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Noel Carlson, PhD	The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Marcelo C. Kremenchutzky, MD, FAAN	No disclosure on file
Ramandeep Sahni, MD	Dr. Sahni has nothing to disclose.
Mathias Baehr	No disclosure on file
Laura E. Baldassari, MD, MHS	No disclosure on file
Carl Langefeld	No disclosure on file
Maureen A. Mealy, PhD, RN	No disclosure on file
Jon Williams, DO, PhD	Dr. Williams has nothing to disclose.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Danny Samkutty, MD	Dr. Samkutty has nothing to disclose.
Sharjeel Panjwani, MD	No disclosure on file
Mohammed Alqahtani	Mohammed Alqahtani has nothing to disclose.
Jose Maria Cabrera Maqueda	Mr. Cabrera Maqueda has nothing to disclose.
Jasvinder K. Atwal, PhD	No disclosure on file
Stanton B. Elias, MD	No disclosure on file
Dusan Stefoski, MD, FAAN	No disclosure on file
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Michael A. Vogelbaum, MD, PhD, FACS	No disclosure on file
Amer Malik, MD	Dr. Malik has nothing to disclose.
Joo Yeon Nam, MD	No disclosure on file
Daniel Savitt, MD	No disclosure on file
Caroline Miranda, MD	No disclosure on file
Reina Fuji	No disclosure on file
Huw R. Morris, MD, PhD	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Alexandra M. Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
Tamara Castillo-Trivino, MD, MAS, FAAN	Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Elena Schmidt, MD	Dr. Schmidt has nothing to disclose.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Prateek Thatikunta, MD	No disclosure on file
Mariana Espinosa-Polanco	No disclosure on file
John Vest	John Vest has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. John Vest has received stock or an ownership interest from Alnylam Pharmaceuticals. John Vest has received intellectual property interests from a discovery or technology relating to health care.
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Stephan Schmidt, MD	No disclosure on file
Roberto Bergamaschi	Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Yara D. Fragoso	Yara D. Fragoso has nothing to disclose.
Simona Malucchi	No disclosure on file
Esther Bui, MD	Dr. Bui has received publishing royalties from a publication relating to health care.
O. C. Snead III, MD, FAAN	Dr. Snead has nothing to disclose.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Serkan Ozakbas, MD	Dr. Ozakbas has nothing to disclose.
Gerardo Iuliano, PhD	Dr. Iuliano has nothing to disclose.
Paraskevi Sakka, MD, PhD	No disclosure on file
Marco Alfonso Narduc Capobianco	Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Marco Alfonso Narduc Capobianco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Sommer Ebdlahad Philips, MD	No disclosure on file
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Annie S. Daniel, MBBS	Dr. Daniel has nothing to disclose.
Ryan T. Merrell, MD	No disclosure on file
Marco Lima	No disclosure on file
Cavit Boz, MD	Dr. Boz has nothing to disclose.
Ovais Inamullah, MD	Dr. Inamullah has nothing to disclose.
Ali Hejazi, MD, PhD	No disclosure on file
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Alexandra E. Jacob, MS	No disclosure on file
Ruchira M. Jha, MD	Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Nadja Borisow	No disclosure on file
Maria Malentacchi	No disclosure on file
Anil Venkitachalam, MD	No disclosure on file
Brian M. Andersen, MD	No disclosure on file
Reydmar Lopez	Reydmar Lopez has nothing to disclose.
Hao Zhang, PhD	No disclosure on file
Anton P. Porsteinsson, MD	Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognitive Research Corporation. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Athira. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Porsteinsson has received research support from Alector. The institution of Dr. Porsteinsson has received research support from Eisai. The institution of Dr. Porsteinsson has received research support from Eli Lilly. The institution of Dr. Porsteinsson has received research support from Athira. The institution of Dr. Porsteinsson has received research support from Genentech/Roche. The institution of Dr. Porsteinsson has received research support from Cassava. The institution of Dr. Porsteinsson has received research support from Vaccinex.
Raquel Gardner, MD	Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Manish Modi	No disclosure on file
Vesper F. Ramos, MD	Dr. Ramos has received personal compensation for serving as an employee of Pfizer. Dr. Ramos has or had stock in Pfizer.
Catherine Maurice, MD	No disclosure on file
Chrstoph Lassek	No disclosure on file
Fernando Santos Pinheiro, MD	No disclosure on file
Yvo A. Rodriguez-Linares, MD	Dr. Rodriguez-Linares has nothing to disclose.
Roy A. Poblete, MD	No disclosure on file
Sami Alkasab, MD	Dr. Alkasab has nothing to disclose.
Ih Chang	Ih Chang has received personal compensation for serving as an employee of Cerevel. Ih Chang has received stock or an ownership interest from Cerevel Therapeutics.
Dimitrios Karussis, MD, PhD	Prof. Karussis has nothing to disclose.
Michael Levy, MD, PhD, FAAN	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Jeannette Lechner-Scott, MD, PhD, FRACP	The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Carlen A. Yuen, MD	Dr. Yuen has nothing to disclose.
Jinny Min	No disclosure on file
Lysa Boissé Lomax, MD	Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, Eisai, Sunovion. Dr. Boissé Lomax has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Correctional Service Canada. The institution of Dr. Boissé Lomax has received research support from UCB.
Lin Zhang, MD, PhD, FAAN	Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation.
Dina Randazzo, DO	No disclosure on file
Nancy Ann Oberheim Bush, MD, PhD	Dr. Oberheim Bush has nothing to disclose.
Giulietta Riboldi, MD	The institution of Dr. Riboldi has received research support from Prevail Therapeutics.
Ellyse K. Probst-Simmons	No disclosure on file
Natalia Rincon, MD	Dr. Rincon has nothing to disclose.
Nan Cheng, MD	Dr. Cheng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Farzad Adl	No disclosure on file
XinLi Du, MD	Dr. Du has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx.
Efthimios Dardiotis	No disclosure on file
Till Sprenger	No disclosure on file
Ali Daneshmand, MD	Dr. Daneshmand has nothing to disclose.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Laura Simionescu, MD	Dr. Simionescu has received publishing royalties from a publication relating to health care.
Aysun Soysal, MD	Dr. Soysal has nothing to disclose.
Eric Lipp	No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN	Dr. Ahmed has nothing to disclose.
Allan G. Kermode, MD, MBBS, FRACP	Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kermode has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Mirela Cerghet, MD, PhD, FAAN	Dr. Cerghet has nothing to disclose.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Christopher Hess, MD	The institution of Dr. Hess has received research support from Parkinson's Foundation.
Diego Silva, MD, PhD	No disclosure on file
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Erika T. Marulanda, MD, FAAN	Dr. Marulanda has nothing to disclose.
Anjali Gera, MD	Dr. Gera has nothing to disclose.
David Valentine, MD	No disclosure on file
Audrey Leasure	Ms. Leasure has nothing to disclose.
Daniel S. Eliahu	No disclosure on file
Sarah Sung, MD	No disclosure on file
Anusha Yeshokumar, MD	Dr. Yeshokumar has nothing to disclose.
Jonathan Rosand, MD	Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Murat Terzi, PhD	Dr. Terzi has nothing to disclose.
Altaf Saadi, MD, MSc, FAAN	The institution of Dr. Saadi has received research support from ��ɫ��. The institution of Dr. Saadi has received research support from National Science Foundation. The institution of Dr. Saadi has received research support from Russel Sage Foundation. The institution of Dr. Saadi has received research support from National Institute of Health.
Erik Z. Krause, DO	No disclosure on file
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Vijayaleskhmi Nair, MD	No disclosure on file
Timothy B. Saurer, PhD	Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Armin Maghsoudlou, MD	Dr. Maghsoudlou has nothing to disclose.
Bhavani Kashyap, MBBS, PhD	Dr. Kashyap has nothing to disclose.
Arjumond Khan	No disclosure on file
Patrick M. Kochanek, MD, MCCM	Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Washington. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Johns Hopkins Health System. Patrick M. Kochanek, MD, MCCM has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for de Boisblanc Law Firm. The institution of Patrick M. Kochanek, MD, MCCM has received research support from Chuck Noll Foundation. The institution of Patrick M. Kochanek, MD, MCCM has received research support from NIH. Patrick M. Kochanek, MD, MCCM has received publishing royalties from a publication relating to health care.
Tamar Bacon	The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Rocio Hernandez Clares, MD, PhD	No disclosure on file
Randy Robinson, PhD	No disclosure on file
Nadeem I. Khan, MD	Dr. Khan has nothing to disclose.
Hamidreza Saber, MD	No disclosure on file
Peter R. Bergethon, MD, FAAN	No disclosure on file
Matthew T. Lorincz, MD, PhD	Dr. Lorincz has received personal compensation for serving as an employee of Alexion. Dr. Lorincz has received personal compensation for serving as an employee of Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Lorincz has received research support from Alexion.
Shoichi Shimamoto, MD	No disclosure on file
Shannon W. Mendes, PhD	No disclosure on file
Maria Raquel Lopez, MD, FAAN	Dr. Lopez has nothing to disclose.
Björn Tackenberg, MD, FAAN	Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Michael Lang	No disclosure on file
Ali Mohammed Alshehri, MD	Dr. Alshehri has nothing to disclose.
Khalid S. Alqadi, MD	No disclosure on file
Maria Rodriguez Rodriguez, MD	Maria Rodriguez Rodriguez, MD has nothing to disclose.
Antonio Pato	Antonio Pato has nothing to disclose.
Masoud Majed, MD	Dr. Majed has nothing to disclose.
Jennifer L. Nichols, MD	No disclosure on file
Luciano A. Sposato, MD	Dr. Sposato has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Sposato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Gore.
Mark Armanious, MD	Dr. Armanious has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME ��ɫ��. Dr. Armanious has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi.
Ivan Cuesta Isabel, MD	No disclosure on file
Mark Keegan, MD, FAAN	Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Michael Christiansen, MD	No disclosure on file
Ahmad El Kouzi, MD, FAAN	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Michael H. Kohrman, MD	No disclosure on file
Omar M. Wazzan, MD	No disclosure on file
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Vivek Rai, MD	Dr. Rai has nothing to disclose.
Ikjae Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Welton O'Neal, Jr., PharmD	No disclosure on file
Bing Zhu, MD	No disclosure on file
Jeffrey Weinberg	No disclosure on file
Mallory Hacker, PhD	Dr. Hacker has nothing to disclose.
Jennifer Haynes, MD	Dr. Haynes has nothing to disclose.
Arnon Karni, MD, PhD	Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Prof. Karni has received research support from Medison. The institution of Prof. Karni has received research support from BMS. The institution of Prof. Karni has received research support from Novartis.
Ravi Patel, MD, MBA, FAHA	No disclosure on file
Louise D. McCullough, MD, PhD	The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Kendra R. Cagniart, MD	Dr. Cagniart has nothing to disclose.
Melissa Naylor	Ms. Naylor has received personal compensation for serving as an employee of Takeda. Ms. Naylor has stock in Takeda.
Takeshi Ikeuchi, MD	Dr. Ikeuchi has nothing to disclose.
Francis M. Huttinger, MD	No disclosure on file
Deepak K. Gupta, MBBS	The institution of Dr. Gupta has received research support from Department of Defense.
Michael Wong, MD, PhD	No disclosure on file
Ross Zafonte, DO	Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care.
Amie L. Hiller, MD	The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Joyce A. Cramer	No disclosure on file
Guangbin Xia, MD, PhD	No disclosure on file
Jignesh J. Shah, MD	No disclosure on file
Vijeta Shukla, MD	No disclosure on file
Heidi L. Henninger, MD, FAAN	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Youssef Al Said, MBBS	No disclosure on file
Glenn Lesser	No disclosure on file
Haralambos Alexopoulos	No disclosure on file
Sarah Zubkov, MD	No disclosure on file
Benjamin Emanuel, DO	Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Jennifer Petrillo Billet, PhD	Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Christopher Liong	No disclosure on file
Jeffrey A. Kaye, MD, FAAN	Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Anthony Reder, MD	Dr. Reder has nothing to disclose.
Florencia Aguirre	No disclosure on file
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Bhavana Sharma, MD	No disclosure on file
Guru Ramaiah, MD	No disclosure on file
Catalina Bensi	No disclosure on file
Lucia J. Zavala	Ms. Zavala has nothing to disclose.
Antoaneta J. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen.
Maria Martinez-Lage, MD	The institution of Dr. Martinez-Lage has received research support from NIH.
Anita K. Mehta, MD	Dr. Mehta has nothing to disclose.
Lucas Elijovich, MD	No disclosure on file
Timothy Spelman	No disclosure on file
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
Monica E. Loghin, MD	Dr. Loghin has nothing to disclose.
Darcy Krueger, MD	Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Nawaz Hack, MD	Dr. Hack has nothing to disclose.
Nadav Bleich Kimelman	Nadav Bleich Kimelman has nothing to disclose.
Ehud Marom	Mr. Marom has received personal compensation for serving as an employee of Mapi Pharma. Mr. Marom has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Mapi Pharma. Mr. Marom has stock in Mapi Pharma. Mr. Marom has received intellectual property interests from a discovery or technology relating to health care.
Sharon Chen	No disclosure on file
Jang Yun	No disclosure on file
Jeffrey A. Switzer, DO, FAAN	Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Expert Speaker on a panel with Genentech. Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with SAA Alumni Association.
Lluis Ramio	No disclosure on file
Francisco Javier Olascoaga Urtaza, MD	No disclosure on file
Francois Bethoux, MD	No disclosure on file
Konark Malhotra, MD	Dr. Malhotra has nothing to disclose.
Matthew K. Zabel, PhD	No disclosure on file
Malik Adil, MBBS	No disclosure on file
R E. Faught, Jr., MD, FAAN	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Shuichi Suzuki, MD, PhD	No disclosure on file
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Stephen B. Tatter, MD	The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Mouhammad A. Jumaa, MD	Dr. Jumaa has nothing to disclose.
Joshua M. Shulman, MD, PhD, FAAN	Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Wei Hu, MD, PhD	No disclosure on file
Bart Van Wijmeersch, MD, PhD	Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/Bristol Myers Group. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Pharmaceutics. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Van Wijmeersch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Prof. Van Wijmeersch has received research support from Merck. The institution of Prof. Van Wijmeersch has received research support from Roche.
Maria Naylor, PhD	Dr. Naylor has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Naylor has stock in Biogen. Dr. Naylor has stock in Dyne Therapeutics.
Shuja Sheikh, MD	No disclosure on file
Michael Chan	No disclosure on file
Yathish Haralur, MD	Dr. Haralur has nothing to disclose.
Valeria Lujan Salutto	Valeria Lujan Salutto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion astrszeneca.
Eric Engebretson	Mr. Engebretson has nothing to disclose.
Luca Marinelli	Luca Marinelli has received personal compensation for serving as an employee of General Electric.
Caila B. Vaughn, PhD	No disclosure on file
Pyay San	No disclosure on file
Channa Kolb, MD	No disclosure on file
Takuya Konno, MD, PhD	No disclosure on file
Dana L. McDermott, DO	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.
Andrea P. Lee, MD	Dr. Lee has nothing to disclose.
Mark J. Fisher, MD	The institution of Dr. Fisher has received research support from NIH.
Sona Shah, MD	No disclosure on file
Arunkumar B. Shah, MD, DM	No disclosure on file
Jonathan Jagid	Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Sara Golas	No disclosure on file
Steven M. Bromley, MD, FAAN	No disclosure on file
Katherine Mortati, MD	Dr. Mortati has nothing to disclose.
Peter B. Barker, MD	No disclosure on file
Ayman P. Tourbah	No disclosure on file
Talora Martin, MD	No disclosure on file
Teri R. Thomsen, MD	Dr. Thomsen has nothing to disclose.
Rafael Arroyo	No disclosure on file
Adam L. Hartman, MD, FAAP, FCNS, FAES, FAAN	Dr. Hartman has received personal compensation for serving as an employee of NINDS/NIH.
Ju-Hong Min, MD	No disclosure on file
Amber L. Ward	No disclosure on file
Rizwana Rehman	No disclosure on file
Brian Steingo, MD	Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. The institution of Dr. Steingo has received research support from Infinity Clinical Research.
Yedatore S. Venkatesh, MD, FAAN	Dr. Venkatesh has nothing to disclose.
Jeffrey A. Wilken, PhD	No disclosure on file
Brian Berman, MD, MS, FAAN	The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Gian D. Pal, MD	Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Varun Chauhan, MD	No disclosure on file
Ava Puccio, PhD, RN	Dr. Puccio has nothing to disclose.
Neil W. Thomas, MD	The institution of Dr. Thomas has received research support from The Alzheimer's Association. Dr. Thomas has received publishing royalties from a publication relating to health care.
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Mini Singh, MBBS	Dr. Singh has nothing to disclose.
Fang-Chi Hsu	No disclosure on file
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Mohammed S. Sanjak, PhD	No disclosure on file
Cinzia Cordioli, MD	Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Rosa Capozzo	No disclosure on file
David Cachia, MD	Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
Pei-Ran Ho	No disclosure on file
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Catherine Austin	No disclosure on file
Nydia A. Lorenzana-Mendoza, MD	No disclosure on file
Sajid Suriya, MD	Dr. Suriya has nothing to disclose.
Ambooj Tiwari, MD	Dr. Tiwari has nothing to disclose.
Ken Myers, MD, PhD	Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AS2Bio. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Pediatric Research Foundation. The institution of Dr. Myers has received research support from Montreal Children's Hospital Foundation. The institution of Dr. Myers has received research support from CQDM/Pharma Liam. The institution of Dr. Myers has received research support from CIHR.
Joseph J. Higgins, MD, FAAN	No disclosure on file
Marco Capobianco, MD	No disclosure on file
Donna C. Graves, MD, FAAN	Dr. Graves has nothing to disclose.
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Richa Tripathi, MD	Dr. Tripathi has nothing to disclose.
Yuichi Iwaki	No disclosure on file
Stephanie Licata	Stephanie Licata has received personal compensation for serving as an employee of Biogen. Stephanie Licata has received stock or an ownership interest from Biogen.
Lalanthica Yogendran, MD	The institution of Dr. Yogendran has received research support from Incyte. The institution of Dr. Yogendran has received research support from Dana Farber . The institution of Dr. Yogendran has received research support from FALK Catalyst. Dr. Yogendran has received personal compensation in the range of $0-$499 for serving as a speaker at community conference with Parkinson Support and Wellness. Dr. Yogendran has received personal compensation in the range of $500-$4,999 for serving as a speaker at local conference with University of Cincinnati.
Ke Zeng, PhD	No disclosure on file
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Francesco Sacca, MD, FAAN	Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Zhenyuan Wang, PhD	Dr. Wang has nothing to disclose.
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Kristin Halvorsen	No disclosure on file
Kate M. Essad, MD, FAAN	Dr. Essad has nothing to disclose.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Shinji Ito	No disclosure on file
Natalie Kukulka, MD	Dr. Kukulka has nothing to disclose.
Muhammad S. Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Colleen G. Lechtenberg, MD	The institution of Dr. Lechtenberg has received research support from The Department of Neurology.
Ernst-Wilhelm Radue, MD	Dr. Radue has nothing to disclose.
Fahad S. Al-Ajlan, MD	Dr. Al-Ajlan has nothing to disclose.
Cigdem Isitan-Alkawadri, MD	Dr. Isitan-Alkawadri has nothing to disclose.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Christopher D. Lee, MD	Dr. Lee has nothing to disclose.
Janice M. Redmond, MD	Dr. Redmond has nothing to disclose.
Becky J. Parks, MD	Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Stefan Braune	Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Josef M. Gutman, MD	Dr. Gutman has nothing to disclose.
Leonardo Almeida	No disclosure on file
Adam Brickman, PhD	Adam Brickman, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IQVIA. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cognito Therapeutics. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Illinois. Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Adam Brickman, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. Adam Brickman, PhD has stock in Tau Biosciences. Adam Brickman, PhD has stock in CogniScreen.
Jyh Yung Hor, MD	No disclosure on file
Maureen Neary	No disclosure on file
Evan A. Jolliffe, MD	No disclosure on file
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Geetha Chari, MD, FAAN	Dr. Chari has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Egemen Idiman, MD	No disclosure on file
Christopher Y. Way, DO	No disclosure on file
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Elisabetta Sarasso	Elisabetta Sarasso has nothing to disclose.
Frederic Sedel	No disclosure on file
Kelianne Cummings	No disclosure on file
Kanita Beba Abadal, MD	Dr. Beba has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Alexandra Golby	No disclosure on file
Glen H. Stevens, DO, PhD, FAAN	The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute.
Cynthia L. Sullivan, PhD	No disclosure on file
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Valentin Laticevschi, MD	No disclosure on file
Wei Xu	No disclosure on file
CARLOS MAURICIO M. MILLAN, MD	Dr. Millan has nothing to disclose.
Amanda L. Witt, MD	No disclosure on file
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Ovidiu C. Andronesi	No disclosure on file
Karisa C. Schreck, MD, PhD	Dr. Schreck has received personal compensation in the range of $0-$499 for serving as a Consultant for Nurix. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics.
Steven W. Anderson, PhD	Dr. Anderson has nothing to disclose.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Alison Baird, MBBS, PhD, FRACP, MPH	The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from Research Foundation of SUNY. Dr. Baird has received intellectual property interests from a discovery or technology relating to health care. Dr. Baird has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Maimonides Medical Center.
Eleonora Cocco	No disclosure on file
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Derek W. Stitt, MD	Dr. Stitt has nothing to disclose.
Shashank Agarwal, MD, MBBS	Dr. Agarwal has nothing to disclose.
Elisabetta Signoriello	Elisabetta Signoriello has nothing to disclose.
Wendy Agnese	No disclosure on file
Vladimir S. Kostic, MD, PhD	Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of ��ɫ��, Science and Technological Development of Serbia.
Elena Bravver, MD	No disclosure on file
Pietro Annovazzi	No disclosure on file
Ryna Then, MD	Dr. Then has nothing to disclose.
Jean Philippe Ranjeva	No disclosure on file
Joanna Dojillo, MSc	No disclosure on file
Alice Laroni	Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alice Laroni has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alice Laroni has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alice Laroni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Alice Laroni has received research support from Fondazione Italiana Sclerosi MUltipla . The institution of Alice Laroni has received research support from Ministero Salute. The institution of Alice Laroni has received research support from Ministero UNiversità.
Naymee J. Velez-Ruiz, MD	Dr. Velez-Ruiz has nothing to disclose.
Bhumika Balgobin, MD	No disclosure on file
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Rohit Gummi, MD	Dr. Gummi has nothing to disclose.
Lucy Zhang, MD	Dr. Zhang has nothing to disclose.
Mei-Sheng Duh, MPH, ScD	No disclosure on file
Brandon P. Moss, MD	An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Mary Jo Pugh, PhD, RN, FAAN	The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic ��ɫ�� Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Dolora R. Wisco, MD	Dr. Wisco has nothing to disclose.
Sarah E. Nelson, MD, MPH, FAAN	Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal. Dr. Nelson has received publishing royalties from a publication relating to health care. Dr. Nelson has a non-compensated relationship as a Women Leading in Neurology Program with ��ɫ�� that is relevant to AAN interests or activities.
Rejo Cherian, MD	Dr. Cherian has nothing to disclose.
Hadi Maghzi, MD	No disclosure on file
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Nikolaos Scarmeas, MD, FAAN	Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Arnfin Bergmann	Dr. Bergmann has nothing to disclose.
Nicolas Chrestian, MD	Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Chrestian has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Peer choice.
Christopher C. Spears, MD	Dr. Spears has nothing to disclose.
Ziv Gan-Or, MD, PhD	Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care.
Erica H. Parrotta, DO	No disclosure on file
Kavneet Kaur, MD	Dr. Kaur has nothing to disclose.
Stefania Maraka, MD	Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SpringWorks Therapeutics . The institution of an immediate family member of Dr. Maraka has received research support from Baxter.
Ellen S. Lathi, MD	No disclosure on file
Marie Beaudin, MD	Dr. Beaudin has nothing to disclose.
Stephen J. Marks, MD	No disclosure on file
Marcos G. Burgos, MD	No disclosure on file
Jacob Mandel, MD	Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER PHARMACEUTICALS LLC (US). Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BAYER HEALTHCARE PHARMACEUTICALS (US.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Eddie Jones, BA	Eddie Jones, BA has nothing to disclose.
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Neha Prakash, MD	The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Atefeh Katrahmani	No disclosure on file
Phyllis Faust	Phyllis Faust has nothing to disclose.
Juan Ignacio Rojas, MD	Dr. Rojas has nothing to disclose.
Felippe Borlot, MD	Dr. Borlot has nothing to disclose.
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Giorgio Giannattasio	No disclosure on file
Jean P. Hubble, MD	No disclosure on file
Christopher L. Groth, MD	Dr. Groth has nothing to disclose.
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Kazuko Matsuda, MD	No disclosure on file
Arianna Sartori, MD	No disclosure on file
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Tarun D. Singh, MBBS	Dr. Singh has nothing to disclose.
Zhe Wang	No disclosure on file
Charlotte A. Merrill, PhD	No disclosure on file
Matthew T. McCarthy, MD	No disclosure on file
Yoshiki Niimi	Yoshiki Niimi has nothing to disclose.
Reza Seyedsadjadi, MD	Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Florian P. Thomas, MD, PhD, MA, FAAN	Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Marinos C. Dalakas, MD, FAAN	Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Joseph F. Quinn, MD, FAAN	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Kazuko Hasegawa, MD	Dr. Hasegawa has nothing to disclose.
Sun Ju Chung, MD, PhD, FAAN	Dr. Chung has nothing to disclose.
Syed F. Zaidi, MD	Dr. Zaidi has nothing to disclose.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Georgios Tsivgoulis, MD, FAAN	Dr. Tsivgoulis has nothing to disclose.
Melanie Glenn, MD	No disclosure on file
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Michelle Feese	No disclosure on file
Muhammad Niazi, MD	No disclosure on file
John Boscardin	No disclosure on file
Neha Kumar	No disclosure on file
Ichiro Yabe, MD, PhD	Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DaiichiSankyo. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SumitomoPharma. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for KyowaKirin. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Japan. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly Japan. The institution of Dr. Yabe has received research support from Toppan. The institution of Dr. Yabe has received research support from Ceres. The institution of Dr. Yabe has received research support from Hakuyo-Kai. The institution of Dr. Yabe has received research support from Choan-Kai.
Sebina Bulic, MD	Dr. Bulic has nothing to disclose.
Paul B. Ferguson, MD, FAAN	Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Un J. Kang, MD, FAAN	Dr. Kang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Experimental Neurology. The institution of Dr. Kang has received research support from NIH. The institution of Dr. Kang has received research support from Parkinson's Foundation. The institution of Dr. Kang has received research support from Michael J Fox Foundation for Parkinson's Research.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Shu-Ing Chang	No disclosure on file
Julia Pakpoor, MBBS	No disclosure on file
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Elizabeth H. Wise, APRN	Ms. Wise has nothing to disclose.
Gerson Suarez-Cedeno, MD	Dr. Suarez-Cedeno has nothing to disclose.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
David M. Ermak, DO	Dr. Ermak has nothing to disclose.
Hermelinda Abcede, MD	Dr. Abcede has nothing to disclose.
Annick DesJardins, MD	Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biodexa. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix Therapeutics. Dr. DesJardins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chimerix. Dr. DesJardins has stock in Istari Oncology. Dr. DesJardins has received intellectual property interests from a discovery or technology relating to health care.
Peggy Nguyen, MD	Dr. Nguyen has nothing to disclose.
Bruce R. Korf, MD	Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Pharmaceuticals. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Healx. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recursion. Dr. Korf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genome Medical. Dr. Korf has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Infixion. Dr. Korf has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Human Genetics. Dr. Korf has stock in Genome Medical. The institution of Dr. Korf has received research support from NIH. The institution of Dr. Korf has received research support from Department of Defense. The institution of Dr. Korf has received research support from Children's Tumor Foundation. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care.
Judith Haas, MD	No disclosure on file
Jerome J. Graber, MD, MPH, FAAN	Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with ��ɫ�� that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Eric H. Kossoff, MD	Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Kossoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simply Good Foods. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cambrooke. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care.
Matthew N. Meriggioli, MD, FAAN	Dr. Meriggioli has received personal compensation for serving as an employee of Novartis Gene Therapies. Dr. Meriggioli has received stock or an ownership interest from Novartis.
Koji Fujita, MD, PhD	No disclosure on file
Mamta B. Singh, MD, MBBS, DM, FAAN	Dr. Singh has nothing to disclose.
Enrique A. Serrano, MD	No disclosure on file
Shawniqua Williams Roberson, MD	Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. The institution of Dr. Williams Roberson has received research support from National Institute on Mental Health . Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Visiting Speaker with University of Pennsylvania. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Faculty Speaker with the International Symposium for Intensive Care and Emergency Medicine.
Tatsuro M. Mutoh, MD, PhD, FAAN	Dr. Mutoh has nothing to disclose.
Mackenzie Cervenka, MD	Dr. Cervenka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nutricia. Dr. Cervenka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle Health Science/Vitaflo. The institution of Dr. Cervenka has received research support from Nestle Health Science/Vitaflo. Dr. Cervenka has received publishing royalties from a publication relating to health care.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Laurent D. Kremer	Laurent D. Kremer has nothing to disclose.
John Snowden	John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS.
Kyle Carpenter, DO	No disclosure on file
William Cho	No disclosure on file
Gurtej Singh, MD	Dr. Singh has nothing to disclose.
Ketan Jhunjhunwala, MD	No disclosure on file
Agustin Oterino Duran, MD	No disclosure on file
Edward Pan, MD	No disclosure on file
Ana Rodriguez Regal	Ana Rodriguez Regal has nothing to disclose.
Divya B. Mella, MD	No disclosure on file
Alejandra Gonzalez	No disclosure on file
Claudia F. Lucchinetti, MD, FAAN	The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Muhammad Ibrahimi, MD	No disclosure on file
Miriam M. Sklerov, MD	The institution of Dr. Sklerov has received research support from National Institutes of Health (NIH). The institution of Dr. Sklerov has received research support from University of North Carolina Department of Medicine.
Eva Costa Arpin, MD	No disclosure on file
Jessica A. Sagen, MA	Ms. Sagen has nothing to disclose.
Shai Rubnov	Shai Rubnov has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Mapi pharma.
David P. Bissig, MD	Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Ronit Gilad	Ms. Gilad has nothing to disclose.
larry rubin	No disclosure on file
Geoffrey Manley, MD, PhD	The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board.
Andrea Almeida, MD	Dr. Almeida has nothing to disclose.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Xue Ming, MD	Dr. Ming has nothing to disclose.
Joab Chapman, MD, PhD	Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Stephen N. Scelsa, MD	No disclosure on file
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Daniel H. Selchen, MD	Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva.
Edward J. Cupler, MD, FAAN	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Csilla Csoboth	No disclosure on file
Ines Gonzalez	Ines Gonzalez has nothing to disclose.
Lauren P. Miller, NP	No disclosure on file
Kye Won Park, MD	Dr. Park has nothing to disclose.
Nicole Vrettos	Ms. Vrettos has nothing to disclose.
Harmanpreet Tiwana, MD	No disclosure on file
Surabhi Kaul, MD	No disclosure on file
Preeti M. Rao, MD	No disclosure on file
Joel Kline	No disclosure on file
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Timothy Bernard, MD	The institution of Dr. Bernard has received research support from NIH.
Ramses Ribot, MD	No disclosure on file
Karen Medin, DO	No disclosure on file
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Ahmet Onur Keskin, MD	No disclosure on file
Nirosen Vijiaratnam, MD	No disclosure on file
Merredith R. Lowe, MD	No disclosure on file
Jeffrey Dawson	Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN	The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Joseph M. Palumbo, MD	Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stalicla SA. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Psychae Therapeutics Pty Ltd. Dr. Palumbo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phocus Pharmaceuticals Inc.. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has or had stock in BioVie. An immediate family member of Dr. Palumbo has or had stock in Merck Research Laboratories. The institution of Dr. Palumbo has received research support from United States Department of Defense. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Julia N. Bucklan, DO	Dr. Bucklan has nothing to disclose.
Rabia Jamy, MD	Dr. Jamy has nothing to disclose.
Natasha Hameed, MD	Dr. Hameed has nothing to disclose.
Sonia M. Caraballo-Cartagena, MD	Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
David R. Williams, MD, MBBS	No disclosure on file
David Turkel-Parrella, MD	No disclosure on file
Jessika Suescun, MD	Dr. Suescun has nothing to disclose.
Chris Tang, MD	No disclosure on file
Helen A. Valsamis, MD	Dr. Valsamis has nothing to disclose.
Ashley P. Ghiaseddin, MD, FAAN	Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neosoma. Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Deciphera. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio. Dr. Ghiaseddin has or had stock in CRISPR Therapeutics AG.
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Ina Ly, MD	An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care.
Alexandra Tomic	No disclosure on file
Myassar Zarif	Myassar Zarif has nothing to disclose.
Jillian Smith	Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
Matthew T. Sweney, MD	No disclosure on file
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Teresa Ayuso, MD	No disclosure on file
Luciana Melamud	No disclosure on file
Sofia Akrivou	No disclosure on file
James Fryer	James Fryer has received intellectual property interests from a discovery or technology relating to health care.
Uri Danon	Uri Danon has received personal compensation for serving as an employee of Mapi harma.
Victoria Fernandez	Victoria Fernandez has nothing to disclose.
Joseph Legacy, MD	No disclosure on file
Priyanka Chilakamarri, MD	Dr. Chilakamarri has nothing to disclose.
Guillermo R. Delgado-Garcia, MD, MSc	Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Nathan Tagg, MD	Dr. Tagg has stock in Apple, Birkshire Hathaway, Medtronic.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Eugenio Pucci	No disclosure on file
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Joshua L. Kamins, MD	Dr. Kamins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Kamins has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Kamins has received research support from World Boxing Council.
Patrick M. Chen, MD	Dr. Chen has nothing to disclose.
Mary Kay Koenig, MD	Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals.
Wyssem A. Ramdani, MD	No disclosure on file
Francisco Barrero	No disclosure on file
James F. Gusella, PhD	No disclosure on file
Brajesh K. Lal	Brajesh K. Lal has nothing to disclose.
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Emmanuel O. Sanya, MD	No disclosure on file
Kurt Marhardt	No disclosure on file
Ahmed A. Malik, MD	No disclosure on file
Luke Whitmire, PhD	No disclosure on file
Abdulla Alawadhi, MBBS	Dr. Alawadhi has nothing to disclose.
Marlon Seijo	No disclosure on file
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Tara A. Kimbrough, MD	Dr. Kimbrough has nothing to disclose.
Timothy R. Fullam, MD, FAAN	Dr. Fullam has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. Dr. Fullam has received publishing royalties from a publication relating to health care. Dr. Fullam has received personal compensation in the range of $500-$4,999 for serving as a ALS CDRMP Programmatic Panel with Department of War.
Rafael Arroyo Gonzalez	Rafael Arroyo Gonzalez has nothing to disclose.
Javier Jose Mallada Frechin	No disclosure on file
Hena Waseem, MD	Dr. Waseem has nothing to disclose.
Svetlana Eckert, MD	Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Connie L. Pieper, MD	No disclosure on file
Ihtesham A. Qureshi, MD	No disclosure on file
Scott G. Turner, MD	No disclosure on file
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Sahyli Perez Parra, MD	Dr. Perez Parra has nothing to disclose.
Saeyoan Thirunavukkarasu, MPH, MHA	No disclosure on file
Smeer Salam, MD, MBBS	No disclosure on file
Damon P. Cardenas, PhD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��